EurekaMag Full Text Articles Chapter 50,865

Edelstein, I. 1955: Tumor in an undescended testicle: intra-abdominal seminoma with necrosis and hemorrhage. Journal of the International College of Surgeons 24(5 Part 1): 625-629

Klaus, I.G.; Chernoff, B. 1959: Tumor in one ureter of a horseshoe kidney. Journal of the Albert Einstein Medical Center Philadelphia 7(1): 35-37

De Cuveland, E. 1955: Tumor in the inguinal region--osteochondropathy of spina ilica anterior inferior (tuberculum ilicum). Kinderarztliche Praxis 23(5): 227-231

Jones, R.K. 1951: Tumor in the neck produced by thorotrast spilled into the tissues during an arteriography. Journal of Neuropathology and Experimental Neurology 1(4): 313-315

Davis, R.K.; Stevenson, G.T.; Busch, K.A. 1956: Tumor incidence in normal Sprague-Dawley female rats. Cancer Research 16(3): 194-197

Stewart, S.E.; Eddy, B.E. 1959: Tumor induction by SE polyoma virus and the inhibition of tumors by specific neutralizing antibodies. American Journal of Public Health and the Nation's Health 49: 1493-1496

Kashiwabara, S.; Kashimoto, N.; Uesaka, T.; Wakabayashi, K.; Kamiya, K.; Watanabe, H. 2005: Tumor induction by azoxymethane (AOM) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in F344 rat gastric mucosa featuring intestinal metaplasia caused by X-irradiation. Journal of Experimental and Clinical Cancer Research: Cr 24(2): 305-312

Harnly, M.H.; Burton, L.; Friedman, F.; Kopac, M.J. 1954: Tumor induction in Drosophila melanogaster by injection of e11tu larval fluid. Science 120(3110): 225-227

Looney, W.B.; Hursch, J.B.; Colodzin, M.; Stedman, L.T. 1960: Tumor induction in man following thorotrast (thorium dioxide) administration. Acta - Unio Internationalis Contra Cancrum 16: 435-447

Petersen, R.P.; Campa, M.J.; Sperlazza, J.; Conlon, D.; Joshi, M-Beth.; Harpole, D.H.; Patz, E.F. 2006: Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107(12): 2866-2872

Koch, M.; Beckhove, P.; Op den Winkel, J.; Autenrieth, D.; Wagner, P.; Nummer, D.; Specht, S.; Antolovic, D.; Galindo, L.; Schmitz-Winnenthal, F.H.; Schirrmacher, V.; Büchler, M.W.; Weitz, J.ür. 2006: Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Annals of Surgery 244(6): 986

Xiang, S.-T.; Zhou, S.-W.; Guan, W.; Wang, Q.-Z.; Zhang, B.; Liu, J.-H.; Ye, Z.-Q. 2003: Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer. Zhonghua Nan Ke Xue 9(7): 497-500

Odunsi, K.; Old, L.J. 2007: Tumor infiltrating lymphocytes: indicators of tumor-related immune responses. Cancer Immunity 7: 3

Graf, M.R.; Sauer, J.T.; Merchant, R.E. 2005: Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas. Journal of Neuro-Oncology 73(1): 29-36

Schweinitz, H.A.; Lindner, J.; Freytag, G. 1959: Tumor inhibiting effect of basic substance components (especially glucosamine hydrochloride). Klinische Wochenschrift 37(11): 610-612

Preston, F.W.; Jackson, E.J.; Henegar, G.C. 1960: Tumor inhibiting effect of homologous living cells against a rat lymphosarcoma. Surgical Forum 10: 14-17

Franck, B. 1957: Tumor inhibiting metabolites of streptomycetes. Strahlentherapie 15(Sonderbd. 37): 271-279

Tarnowski, G.S. 1955: Tumor inhibition studies on RC mammary adenocarcinoma. Cancer Research Suppl. 3: 28-31

Takabatake, D.; Fujita, T.; Shien, T.; Kawasaki, K.; Taira, N.; Yoshitomi, S.; Takahashi, H.; Ishibe, Y.; Ogasawara, Y.; Doihara, H. 2007: Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). International Journal of Cancer 120(1): 181-188

Buntina, M.N. 1957: Tumor innervation. Vestnik Otorinolaringologii 19(4): 34-38

Yano, H.; Saito, Y.; Kirihara, Y.; Takashima, J. 2006: Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma. Diseases of the Colon and Rectum 49(12): 1867-1877

Pertuiset, B. 1960: Tumor invasion of the cerebral aqueduct in an infant. Anatomo-clinical and therapeutic study. Neurochirurgia 3: 222-234

Cabanillas, M.; Labandeira, J.; Toribio, J. 2005: Tumor involving the back. Actas Dermo-Sifiliograficas 96(9): 623-625

Ehrlich, A. 1954: Tumor involving the laryngeal cartilages. A.M.A. Archives of Otolaryngology 59(2): 178-185

Bardi, G.; Fenger, C.; Johansson, B.; Mitelman, F.; Heim, S. 2004: Tumor karyotype predicts clinical outcome in colorectal cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(13): 2623-2634

Griffiths, E.A.; Brummell, Z.; Gorthi, G.; Pritchard, S.A.; Welch, I.M. 2006: Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. Journal of Surgical Oncology 93(4): 258-267

Metser, U.; Golan, O.; Levine, C.D.; Even-Sapir, E. 2005: Tumor lesion detection: when is integrated positron emission tomography/computed tomography more accurate than side-by-side interpretation of positron emission tomography and computed tomography?. Journal of Computer Assisted Tomography 29(4): 554-559

Hautkappe, W. 1952: Tumor like chondromatosis of the knee joint capsule with osseous transformations. Langenbecks Archiv für Klinische Chirurgie . Vereinigt Mit Deutsche Zeitschrift für Chirurgie 271(6): 547-555

Penn, H.S. 1952: Tumor lipoids. I. Preparation of a serologically active nonsaponifiable fraction of liver of cancer bearing patients. Journal of the National Cancer Institute 12(6): 1389-1399

Hall, G.C.; Dowdy, A.H.; Penn, H.S.; Bellamy, A.W. 1952: Tumor lipoids. II. Clinical evaluation of a serologically active nonsaponifiable fraction of liver of cancer-bearing patients. Journal of the National Cancer Institute 12(6): 1399-1416

Winkler, C. 1958: Tumor localization by photoscintigraphy with aid of radioisotopes. Strahlentherapie 106(3): 428-434

Argus, M.F.; Hewson, K. 1954: Tumor localization studies with sulfur 35-labeled disulfonamido derivatives of fluorene. British Journal of Cancer 8(4): 698-703

Hyung, W.J.; Lim, J.S.; Cheong, J.H.; Lee, Y.C.; Noh, S.H. 2004: Tumor localization using laparoscopic ultrasound for a small submucosal tumor. Journal of Surgical Oncology 86(3): 164-166

Hellriegel, W. 1960: Tumor localization with an image intensifier and television. Strahlentherapie 111: 468-475

King, E.R.; Henkelmann, C.R. 1957: Tumor localization with radioisotopes. Southern Medical Journal 50(9): 1096-1105

Roswit, B.; Unger, S.M. 1960: Tumor localization with transverse tomography: diagnostic and therapeutic applications. Radiology 74: 705-720

Sarp, S.év.; Fioretta, G.ér.; Verkooijen, H.M.; Vlastos, G.; Rapiti, E.; Schubert, H.; Sappino, A.é-P.; Bouchardy, C. 2007: Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Annals of Surgical Oncology 14(3): 1031-1039

Achen, M.G.; Stacker, S.A. 2006: Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. International Journal of Cancer 119(8): 1755-1760

Zhang, J.-p.; Lü, W.-g.; Chen, H.-z.; Zhou, C.-y.; Xie, X. 2005: Tumor lymphangiogenesis in cervical squamous cell carcinoma and its clinical significance. Zhonghua Yi Xue Za Zhi 85(22): 1551-1554

Van der Auwera, I.; Van den Eynden, G.G.; Colpaert, C.G.; Van Laere, S.J.; van Dam, P.; Van Marck, E.A.; Dirix, L.Y.; Vermeulen, P.B. 2005: Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(21): 7637-7642

Yamanaka, R.; Honma, J.; Tsuchiya, N.; Yajima, N.; Kobayashi, T.; Tanaka, R. 2005: Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. Journal of Neuro-Oncology 72(2): 107-113

Saintigny, P.; Chouahnia, K.; Cohen, R.ég.; Pailler, M.-C.; Brechot, J.-M.; Morere, J.-F.ço.; Breau, J.-L. 2007: Tumor lysis associated with sudden onset of syndrome of inappropriate antidiuretic hormone secretion. Clinical Lung Cancer 8(4): 282-284

Marth, E.; Ascher, W.P.; Pavelka, R.; Möse, J.R. 1989: Tumor lysis of a glioblastoma by Clostridium oncolyticum. Journal of ChemoTherapy 1(4 Suppl): 1177-1178

Cope, D. 2004: Tumor lysis syndrome. Clinical Journal of Oncology Nursing 8(4): 415-416

El Mesbahi, O.; Beaudoin, A.; Louvet, C.; De Gramont, A. 2004: Tumor lysis syndrome after chemotherapy for colon small cell carcinoma. La Revue de Medecine Interne 25(10): 768-769

Lehner, S.G.; Gould, J.E.; Saad, W.E.A.; Brown, D.B. 2005: Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. Ajr. American Journal of Roentgenology 185(5): 1307-1309

Ajzensztejn, D.; Hegde, V.S.; Lee, S.M. 2006: Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(15): 2389-2391

Ozkan, A.; Hakyemez, B.; Ozkalemkas, F.; Ali, R.; Ozkocaman, V.; Ozcelik, T.; Taskapilioglu, O.; Altundal, Y.; Tunali, A. 2006: Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology 48(12): 887-892

Dizdar, O.; Yürekli, B.S.; Pürnak, T.; Aksu, S.; Haznedaroglu, I.C. 2004: Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia. Annals of PharmacoTherapy 38(7-8): 1319-1320

Kenealy, M.K.; Prince, H.M.; Hönemann, D. 2006: Tumor lysis syndrome early after treatment with bortezomib for multiple myeloma. PharmacoTherapy 26(8): 1205-1206; Discussion 1206

Kurt, M.üt.; Eren, O.O.; Engin, H.üs.; Güler, N.üf. 2004: Tumor lysis syndrome following a single dose of capecitabine. Annals of PharmacoTherapy 38(5): 902

Fuente, N.; Mañe, J.M.; Barcelo, R.; Muñoz, A.; Perez-Hoyos, T.; Lopez-Vivanco, G. 2004: Tumor lysis syndrome in a multiple myeloma treated with thalidomide. Annals of Oncology: Official Journal of the European Society for Medical Oncology 15(3): 537

Wright, J.L.; Lin, D.W.; Dewan, P.; Montgomery, R.B. 2005: Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer. International Journal of Urology: Official Journal of the Japanese Urological Association 12(11): 1012-1013

Bubała, H.; Sońta-Jakimczyk, D.; Szczepańska, M.; Szprynger, K. 2003: Tumor lysis syndrome in the course of acute lymphoblastic leukemia as the consequence of prednisone monotherapy. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(86): 182-184

Chanimov, M.; Koren-Michowitz, M.; Cohen, M.L.; Pilipodi, S.; Bahar, M. 2006: Tumor lysis syndrome induced by dexamethasone. Anesthesiology 105(3): 633-634

Hörl, W.H. 2005: Tumor lysis syndrome: risk factors and treatment. Wiener Klinische Wochenschrift 117(1-2): 7-17

Dalgaard, J.B. 1958: Tumor malignus congenitus. Nordisk Medicin 59(15): 526-527

Kumar, P.; Rehani, M.M.; Kumar, L.; Sharma, R.; Bhatla, N.; Chaudhry, R.; Thulkar, S.; Sundaram, K.R.; Kumar, N. 2005: Tumor marker CA-125 as an evaluator and response indicator in ovarian cancer: its quantitative correlation with tumor volume. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 11(2): Cr84-Cr89

Nikolić, B.; Ardalić, D.; Lazić, J. 2006: Tumor marker CA-125 in adnexal inflammatory tumors. Vojnosanitetski Pregled 63(4): 383-385

Imai, Y. 2003: Tumor marker and its clinical significance in diagnosis of colorectal cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 7): 193-196

Beck, S.D.W.; Patel, M.I.; Sheinfeld, J. 2004: Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. Journal of Urology 171(1): 168-171

Feil, G.; Stenzl, A. 2006: Tumor marker tests in bladder cancer. Actas Urologicas Espanolas 30(1): 38-45

Crawford, N.P.S.; Colliver, D.W.; Galandiuk, S. 2003: Tumor markers and colorectal cancer: utility in management. Journal of Surgical Oncology 84(4): 239-248

Sánchez de Cos Escuín, J.; Hernández Hernández, J. 2004: Tumor markers and lung cancer. What's new?. Archivos de Bronconeumologia 40 Suppl. 6: 35-40

Shiraishi, T. 2005: Tumor markers associated with brain tumors. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 271-279

Numa, F. 2004: Tumor markers for cancer of the uterine cervix. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 109-112

Yokoyama, M.; Uchiyama, M.; Iwasaka, T.; Fukuda, K. 2004: Tumor markers for carcinoma of the endometrium. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 299-302

Nakaizumi, A.; Tanaka, S. 2006: Tumor markers for detecting pancreatic cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 144-147

Aoki, D.; Kataoka, F.; Susumu, N.; Nozawa, S. 2004: Tumor markers for ovarian cancers. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 10): 496-502

Takezako, Y.; Okusaka, T.; Ueno, H.; Ikeda, M.; Morizane, C.; Najima, M. 2004: Tumor markers for pancreatic and biliary tract cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1443-1446

Bouvet, M. 2004: Tumor markers for pancreatic cancer: what happens when preoperative CA 19-9 is undetectable?. Annals of Surgical Oncology 11(7): 637-638

Oosterwijk, E. 2005: Tumor markers for renal cell carcinoma. Journal of Urology 173(6): 1847

Najima, M.; Okusaka, T. 2006: Tumor markers in biliary tract cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 419-421

Schneider, J. 2006: Tumor markers in detection of lung cancer. Advances in Clinical Chemistry 42: 1-41

Di Cocco, B.; Calabretta, F.; Alghisi, F.; Salesi, N.; Bossone, G. 2003: Tumor markers in epithelial ovarian cancer. Minerva Ginecologica 55(4): 327-332

Jobo, T.; Sato, R.; Kuramoto, H. 2003: Tumor markers in gynecological and breast cancer. Rinsho Byori. Japanese Journal of Clinical Pathology 51(12): 1188-1194

Tsuchiya, N.; Ohyama, C.; Habuchi, T. 2005: Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(2): 275-280

Light, R.W. 2004: Tumor markers in undiagnosed pleural effusions. Chest 126(6): 1721-1722

Leto, G.; Incorvaia, L.; Badalamenti, G.; Arcara, C.; Fulfaro, F.; Tumminello, F.M.; Flandina, C.; Crescimanno, M.; Gebbia, N. 2005: Tumor markers in urogynaecological tumors. La Tunisie Medicale 83(Suppl 12): 28

Sławicki, S.ła.; Mroczko, B.; Szmitkowski, M. 2004: Tumor markers of breast cancer. Postepy Higieny i Medycyny Doswiadczalnej 58: 292-300

Shioda, Y.; Kumagai, M.-a. 2005: Tumor markers of childhood cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(5): 699-704

Kubo, S.; Matsukawa, M. 2004: Tumor markers of hepatocellular carcinoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(13): 2203-2206

Kikuchi, H. 2004: Tumor markers of urinary tract carcinoma. Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 371-380

Stieber, P.; Heinemann, V.; Schalhorn, A. 2005: Tumor markers--how they should be applied. MMW Fortschritte der Medizin 147(20): 35; 37-39

Agnantis, N.J.; Goussia, A.C.; Stefanou, D. 2003: Tumor markers. An update approach for their prognostic significance. Part I. In Vivo 17(6): 609-618

Sachdev, M.S.; Tombazzi, C.R. 2006: Tumor markers: an important adjunct to clinical practice. Southern Medical Journal 99(2): 107

Potter, S.R.; Partin, A.W. 2000: Tumor markers: an update on human kallikrein 2. Reviews in Urology 2(4): 221-222

Kayaba, H. 2003: Tumor markers: essential diagnostic tools for radiologists. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 63(4): 133-139

Liu, D.-g.; Zhang, W. 2006: Tumor masses in lateral ventricle of brain. Zhonghua Bing Li Xue Za Zhi 35(8): 500-501

Grossi, F.; Belvedere, O.; Fasola, G.; Ceschia, T.; Meduri, S.; Sibau, A.; Sacco, C.; Bazzocchi, M.; Talmassons, G.; Morelli, A.; Barbone, F.; Sobrero, A. 2004: Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties. Journal of Clinical Epidemiology 57(8): 804-808

Oehme, J. 1962: Tumor meningitis (with a contribution to the differential diagnosis of hypoglycorrhachia). Monatsschrift für Kinderheilkunde 110: 189-190

Mérida, I.; Avila-Flores, A. 2006: Tumor metabolism: new opportunities for cancer therapy. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 8(10): 711-716

Meyer, R. 1958: Tumor metastases in lungs in men and women. Zeitschrift für Krebsforschung 62(3): 356-360

Kruml, J.; Widimsky, J. 1959: Tumor metastases in the heart. Neoplasma 6: 193-211

Kup, W. 1960: Tumor metastases in the tonsil. Archiv für Ohren- Nasen- und Kehlkopfheilkunde 176: 561-563

Dossogne, M. 1952: Tumor metastases to a horseshoe kidney. Journal Belge d'Urologie 20(5): 250-253

Cao, H.-J.; Fang, Y.; Zhang, X.; Chen, W.-J.; Zhou, W.-P.; Wang, H.; Wang, L.-B.; Wu, J.-M. 2005: Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World Journal of Gastroenterology 11(6): 903-907

Criscuoli, M.L.; Nguyen, M.; Eliceiri, B.P. 2005: Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood 105(4): 1508-1514

Bienengraber, A. 1952: Tumor metastasis in the light of allergology. Zentralblatt für Chirurgie 77(43a): 1873-1881

Patscheider, H. 1953: Tumor metastasis in the spleen. Der Krebsarzt 8(7-8): 212-217

Vernon, A.E.; LaBonne, C. 2004: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Current Biology: Cb 14(17): R719-R721

Mizumoto, C.; Hara, M.; Futai, R.; Sawanishi, T.; Shirakawa, K.; Shimoyama, H.; Morikawa, M.; Tomioka, N.; Watanabe, Y.; Tanaka, J-ya.; Nishida, O.; Saiga, T.; Hirose, K. 2005: Tumor microembolism presenting as characteristic patterns of pulmonary perfusion on lung scanning: a case report. Journal of Cardiology 45(1): 33-39

Li, Z.-W.; Dalton, W.S. 2006: Tumor microenvironment and drug resistance in hematologic malignancies. Blood Reviews 20(6): 333-342

Mocellin, S.; Panelli, M.; Wang, E.; Rossi, C.R.; Marincola, F.M. 2002: Tumor microenvironment: what have we learned studying the immune response in this puzzling battlefield?. Tumori 88(6): 437-444

Vaupel, P. 2004: Tumor microenvironmental physiology and its implications for radiation oncology. Seminars in Radiation Oncology 14(3): 198-206

Strausberg, R.L. 2005: Tumor microenvironments, the immune system and cancer survival. Genome Biology 6(3): 211

Zheng, Y.-C.; Tang, Y.-Y.; Zhou, Z.-G.; Li, L.; Wang, T.-C.; Deng, Y.-L.; Chen, D.-Y.; Liu, W.-P. 2004: Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner. World Journal of Gastroenterology 10(22): 3369-3373

Wang, F.; Pan, L.-Q. 2003: Tumor micrometastasis and its treatment with traditional Chinese medicine. Zhong Xi Yi Jie he Xue Bao 1(3): 171-172; 204

Bian, X.-w.; Wang, Q.-l.; Xiao, H.-l.; Wang, J.M. 2006: Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology. Journal of Neuro-Oncology 80(2): 211-213

Turetschek, K.; Preda, A.; Novikov, V.; Brasch, R.C.; Weinmann, H.J.; Wunderbaldinger, P.; Roberts, T.P.L. 2004: Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. Journal of Magnetic Resonance Imaging: Jmri 20(1): 138-144

Shen, Y.; Liu, P.; Zhang, A.; Xu, L. 2005: Tumor microvasculature response to alternated cold and heat treatment. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2005: 6797-6800

Teicher, B.A. 2005: Tumor models for preclinical development of targeted agents. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 63: 43-66

Bhatia, A.; Kast, R.E. 2007: Tumor necrosis factor (TNF) can paradoxically increase on etanercept treatment, occasionally contributing to TNF-mediated disease. Journal of rheumatology 34(2): 447-9; author reply 449-50

Anonymous 2004: Tumor necrosis factor (TNF) inhibitors. Journal of Dermatological Treatment 15(5): 279

Bryde, S.; Grunwald, I.; Hammer, A.; Krippner-Heidenreich, A.; Schiestel, T.; Brunner, H.; Tovar, Günter.E.M.; Pfizenmaier, K.; Scheurich, P. 2005: Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responses. Bioconjugate Chemistry 16(6): 1459-1467

Marchetti, L.; Klein, M.; Schlett, K.; Pfizenmaier, K.; Eisel, U.L.M. 2004: Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. Journal of Biological Chemistry 279(31): 32869-32881

Vermel', A.E. 2005: Tumor necrosis factor a inhibitors in treatment of Crohn's disease. Klinicheskaia Meditsina 83(11): 13-17

Gwozdziewiczová, S.; Lichnovská, R.; Hrebícek, J. 2004: Tumor necrosis factor alfa (TNFalpha) and insulin resistance. Ceskoslovenska Fysiologie 53(4): 167-175

Son, D.-S.; Arai, K.Y.; Roby, K.F.; Terranova, P.F. 2004: Tumor necrosis factor alpha (TNF) increases granulosa cell proliferation: dependence on c-Jun and TNF receptor type 1. Endocrinology 145(3): 1218-1226

Daniel, P.; Mokrowiecka, A.; Gasiorowska, A.; Małecka-Panas, E. 2005: Tumor necrosis factor alpha (TNF-alpha) and its receptors: sTNF-alphaRi i sTNF-alphaRIi in chronic pancreatitis. Polskie Archiwum Medycyny Wewnetrznej 114(1): 639-643

Pyrzak, B.; Wiśniewska, A.; Rymkiewicz-Kluczyńska, B. 2006: Tumor necrosis factor alpha (TNF-alpha) gene G-308A polymorphism relationship to insulin resistance and lipid abnormalities in children with obesity. Endokrynologia Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego: Organ Polskiego Towarzystwa Endokrynologow Dzieciecych 12(3): 171-174

Chandrasekharan, U.M.; Siemionow, M.; Unsal, M.; Yang, L.; Poptic, E.; Bohn, J.; Ozer, K.; Zhou, Z.; Howe, P.H.; Penn, M.; DiCorleto, P.E. 2007: Tumor necrosis factor alpha (TNF-alpha) receptor-Ii is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo. Blood 109(5): 1938-1944

Watanabe, N. 2005: Tumor necrosis factor alpha (TNFalpha). Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 83-85

Cavallo, M.G.; Montali, A.; Monetini, L.; Valente, L.; Mariani, P.; Bifolco, M.; Sirinian, M.I.; Antonini, T.M.; Fioretti, F.; Campagna, F.; Verna, R.; Arca, M. 2005: Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL). Nutrition Metabolism and Cardiovascular Diseases: Nmcd 15(4): 262-269

Xue, X.; Piao, J.-H.; Nakajima, A.; Sakon-Komazawa, S.; Kojima, Y.; Mori, K.; Yagita, H.; Okumura, K.; Harding, H.; Nakano, H. 2005: Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. Journal of Biological Chemistry 280(40): 33917-33925

Lin, J.; Cheng, Y.; Tian, D.; Liao, J.; Liu, N.; Xiong, P.; Liang, K. 2002: Tumor necrosis factor alpha HLA-DRB(1) gene polymorphism and genetic susceptibility to cirrhosis. Zhonghua Nei Ke Za Zhi 41(12): 818-821

Cho, T-Joon.; Lehmann, W.; Edgar, C.; Sadeghi, C.; Hou, A.; Einhorn, T.A.; Gerstenfeld, L.C. 2003: Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. Arthritis and Rheumatism 48(10): 2845-2854

Skayian, Y.; Kreydiyyeh, S.I. 2006: Tumor necrosis factor alpha alters Na+-K+ ATPase activity in rat cardiac myocytes: involvement of NF-kappaB, AP-1 and PGE2. Life Sciences 80(2): 173-180

Boyer, J.F.éd.ér.; Balard, P.; Authier, H.él.èn.; Faucon, B.; Bernad, J.é; Mazières, B.; Davignon, J.-L.; Cantagrel, A.; Pipy, B.; Constantin, A. 2007: Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Research and Therapy 9(2): R22

Iversen, P.O.; Wiig, H. 2005: Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(19 Part 1): 6793-6799

Yamamura, M. 2005: Tumor necrosis factor alpha and beta (TNF-alpha and -beta) in pathogenesis of rheumatoid arthritis. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 145-152

Bauer, B.ör.; Hartz, A.M.S.; Miller, D.S. 2007: Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Molecular Pharmacology 71(3): 667-675

Song, H.-L.; Lü, S.; Liu, P. 2005: Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure. Zhonghua Gan Zang Bing Za Zhi 13(4): 290-293

Klooster, A.R.; Bernier, S.M. 2005: Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Research and Therapy 7(1): R127-R138

Adamy, C.; Le Corvoisier, P.; Candiani, G.; Kirsch, M.; Pavoine, C.; Defer, N.; Bourin, M.C.; Su, J.B.; Vermes, E.; Hittinger, L.; Pecker, E. 2005: Tumor necrosis factor alpha and glutathione interplay in chronic heart failure. Archives des Maladies du Coeur et des Vaisseaux 98(9): 906-912

Paleev, F.N.; Suchkov, S.V.; Kotova, A.A.; Pronina, O.A.; Paleev, N.R. 2004: Tumor necrosis factor alpha and interferon alpha in patients with myocarditis. Kardiologiia 44(11): 34-38

Polak, G.; Kozioł-Montewka, M.; Tarkowski, R.ł; Kotarski, J. 2003: Tumor necrosis factor alpha and interferon gamma levels in peritoneal fluid of infertile women. Ginekologia Polska 74(9): 992-996

Ramos, E.M.; Lin, M.-T.; Larson, E.B.; Maezawa, I.; Tseng, L.-H.; Edwards, K.L.; Schellenberg, G.D.; Hansen, J.A.; Kukull, W.A.; Jin, L.-W. 2006: Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Archives of Neurology 63(8): 1165-1169

Makhija, P.; Yadav, S.; Thakur, A. 2005: Tumor necrosis factor alpha and interleukin 6 in infants with sepsis. Indian Pediatrics 42(10): 1024-1028

Buke, A.C.; Buke, M.; Altuglu, I.E.; Ciceklioglu, M.; Kamcioglu, S.; Karakartal, G.; Huseyinov, A. 2004: Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 13(5): 273-276

Fehrenbacher, J.C.; Burkey, T.H.; Nicol, G.D.; Vasko, M.R. 2005: Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase Ii but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain 113(1-2): 113-122

Wang, X.-M.; Yang, L.-X.; Zhu, S.-J.; Yang, Y.-J.; Guo, C.-M.; Qi, F.; Wei, L.; Shi, Y.-K.; Wang, Y.; Ren, L. 2004: Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling. Zhonghua Nei Ke Za Zhi 43(11): 828-831

Yang, Y-Ling.; Li, J-Peng.; Li, K-Zong.; Dou, K-Feng. 2004: Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis. World Journal of Gastroenterology 10(19): 2898-2900

Kasagi, M.; Huang, Z.; Narita, K.; Shitara, H.; Motegi, T.; Suzuki, Y.; Fujihara, K.; Tanabe, S.; Kosaka, H.; Ujita, K.; Fukuda, M.; Northoff, G. 2017: Association between Scale-Free Brain Dynamics and Behavioral Performance: Functional MRI Study in Resting State and Face Processing Task. Behavioural Neurology 2017: 2824615

Smeets, T.J.M.; Kraan, M.C.; van Loon, M.E.; Tak, P-Peter. 2003: Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis and Rheumatism 48(8): 2155-2162

De Rycke, L.; Vandooren, B.; Kruithof, E.; De Keyser, F.; Veys, E.M.; Baeten, D. 2005: Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis and Rheumatism 52(7): 2146-2158

Tanaka, H.; Khoo, H.Ming.; Dubeau, Fçois.; Gotman, J. 2018: Association between scalp and intracerebral electroencephalographic seizure-onset patterns: A study in different lesional pathological substrates. Epilepsia 59(2): 420-430

Yamaguchi, N.; Kubo, C.; Masuhiro, Y.; Lally, E.T.; Koga, T.; Hanazawa, S. 2004: Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression. Infection and Immunity 72(1): 269-276

Mugnier, Bénédicte.; Roudier, J. 2004: Tumor necrosis factor alpha haplotypes versus tumor necrosis factor alpha -308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis. Arthritis and Rheumatism 50(12): 4075-6; Author Reply 4076-7

Oliveri, C.; Polosa, R. 2006: Tumor necrosis factor alpha in refractory asthma. New England Journal of Medicine 354(19): 2074-2075; Author Reply 2074-2075

Alekperov, R.T.; Timchenko, A.V.; Nasonov, E.L. 2003: Tumor necrosis factor alpha in systemic scleroderma. Klinicheskaia Meditsina 81(12): 4-7

Babbar, N.; Hacker, A.; Huang, Y.; Casero, R.A. 2006: Tumor necrosis factor alpha induces spermidine/spermine N1-acetyltransferase through nuclear factor kappaB in non-small cell lung cancer cells. Journal of Biological Chemistry 281(34): 24182-24192

Norgauer, J.; Dichmann, S.; Peters, F.; Mockenhaupt, M.; Schraufst tter, I.; Herouy, Y. 2003: Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type Ii expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes. European Journal of Dermatology: Ejd 13(2): 124-129

Bittar, M.N.; Carey, J.A.; Barnard, J.B.; Pravica, V.; Deiraniya, A.K.; Yonan, N.; Hutchinson, I.V. 2006: Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Annals of Thoracic Surgery 81(1): 132-137

Trent, J.T.; Kerdel, F.A. 2005: Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. Dermatology Nursing 17(2): 97-107

Shen, W.H.; Yin, Y.; Broussard, S.R.; McCusker, R.H.; Freund, G.G.; Dantzer, R.; Kelley, K.W. 2004: Tumor necrosis factor alpha inhibits cyclin a expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-i induction of new E2F-1 synthesis. Journal of Biological Chemistry 279(9): 7438-7446

Vadlamani, L.; Iyengar, S. 2004: Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy. Congestive Heart Failure 10(6): 289-292

Au, W.Y.; Fung, A.; Wong, K.F.; Chan, C.H.; Liang, R. 2006: Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leukemia and Lymphoma 47(10): 2189-2193

Schmeling, H.; Wagner, U.; Peterson, A.; Horneff, G. 2006: Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 24(1): 103-108

Nancey, S.ép.; Moussata, D.; Graber, I.; Claudel, S.; Saurin, J.-C.; Flourié, B. 2005: Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?. Inflammatory Bowel Diseases 11(6): 559-566

Dirks, A.J.; Leeuwenburgh, C. 2006: Tumor necrosis factor alpha signaling in skeletal muscle: effects of age and caloric restriction. Journal of Nutritional Biochemistry 17(8): 501-508

Widera, D.; Mikenberg, I.; Elvers, M.; Kaltschmidt, C.; Kaltschmidt, B. 2006: Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. Bmc Neuroscience 7: 64

Chen, H.-Y.; Chen, W.-C.; Hsu, C.-M.; Tsai, F.-J.; Tsai, C.-H. 2005: Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. European Journal of Obstetrics Gynecology and Reproductive Biology 122(1): 73-78

Maury, C.P.J.; Liljeström, M.; Laiho, K.; Tiitinen, S.; Kaarela, K.; Hurme, M. 2003: Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis and Rheumatism 48(11): 3068-3076

Wang, L.-C.; Okitsu, C.Y.; Zandi, E. 2005: Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK. Journal of Biological Chemistry 280(9): 7634-7644

Li, Y.-q.; Zhang, Z.-x.; Xu, Y.-j.; Xiong, S.-d.; Yang, Z.; Ni, W.; Chen, S.-x.; Ma, D. 2006: Tumor necrosis factor alpha-induced expression and activity of alveolar macrophages matrix metalloproteinase-9 in chronic obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi 45(1): 38-41

Sharma, N.; Suzuki, H.; He, Q.; Sharma, R.P. 2005: Tumor necrosis factor alpha-mediated activation of c-Jun NH(2)-terminal kinase as a mechanism for fumonisin B(1) induced apoptosis in murine primary hepatocytes. Journal of Biochemical and Molecular Toxicology 19(6): 359-367

Kumar, A.; Lin, Z.; SenBanerjee, S.; Jain, M.K. 2005: Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Molecular and Cellular Biology 25(14): 5893-5903

Moldenhauer, A.; Nociari, M.; Lam, G.; Salama, A.; Rafii, S.; Moore, M.A.S. 2004: Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells. Stem Cells 22(2): 144-157

Wallis, R.S.; Ehlers, S. 2005: Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Seminars in Arthritis and Rheumatism 34(5 Suppl 1): 34-38

Kim, M.Sun.; Sweeney, T.R.; Shigenaga, J.K.; Chui, L.G.; Moser, A.; Grunfeld, C.; Feingold, K.R. 2007: Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism, Clinical and Experimental 56(2): 267-279

Diehl, A.M. 2004: Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clinics in Liver Disease 8(3): 619

Li, J.-p.; Ling, J.-q. 2003: Tumor necrosis factor and lipopolysaccharide affect periodontal ligament cells expressing osteoprotegerin in vitro. Zhonghua Kou Qiang Yi Xue Za Zhi 38(4): 288-291

Seidemann, K.; Zimmermann, M.; Book, M.; Meyer, U.; Burkhardt, B.; Welte, K.; Reiter, A.; Stanulla, M. 2005: Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(33): 8414-8421

Wang, B.; Liu, Y.; Luo, B. 2002: Tumor necrosis factor and nitric oxide in the protective heat stress model. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 20(1): 13-15

Bongartz, T.; Matteson, E.L.; Orenstein, R. 2005: Tumor necrosis factor antagonists and infections: the small print on the price tag. Arthritis and Rheumatism 53(5): 631-635

Furst, D.E.; Wallis, R.; Broder, M.; Beenhouwer, D.O. 2006: Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Seminars in Arthritis and Rheumatism 36(3): 159-167

Ghezzi, P.; Cerami, A. 2004: Tumor necrosis factor as a pharmacological target. Methods in Molecular Medicine 98: 1-8

Brik, R.; Gepstein, V.; Shahar, E.; Goldsher, D.; Berkovitz, D. 2007: Tumor necrosis factor blockade in the management of children with orphan diseases. Clinical Rheumatology 26(10): 1783-1785

Keane, J. 2004: Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 39(3): 300-302

Rodríguez Moreno, C.; López Vázquez, P.; Durán Parrondo, C.; Tato Herrero, F.; Lado Lado, F. 2006: Tumor necrosis factor blocking agents: a review. Part I: Clinical efficacy evaluation. Anales de Medicina Interna 23(1): 37-45

Rodríguez Moreno, C.; López Vázquez, P.; Durán Parrondo, C.; Tato Herrero, F.; Lado Lado, F.; Velasco González, M. 2006: Tumor necrosis factor blocking agents: a review. Part II: safety and recommendations. Anales de Medicina Interna 23(2): 86-92

Russo, P.; Catassi, A.; Malacarne, D.; Margaritora, S.; Cesario, A.; Festi, L.; Mulé, A.; Ferri, L.; Granone, P. 2005: Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activation. Cancer 103(7): 1503-1518

Zhang, M.; Ren, D.; Li, X.; Zhang, J. 1999: Tumor necrosis factor expression in arterial walls of diabetic rats. Journal of Tongji Medical University 19(3): 203-205

Zhang, G. 2004: Tumor necrosis factor family ligand-receptor binding. Current Opinion in Structural Biology 14(2): 154-160

Wang, J.; Fu, Y-Xin. 2005: Tumor necrosis factor family members and inflammatory bowel disease. Immunological Reviews 204: 144-155

Westerberg, M.; Bengtsson, A.; Ricksten, A.; Jeppsson, A. 2004: Tumor necrosis factor gene polymorphisms and inflammatory response in coronary artery bypass grafting patients. Scandinavian Cardiovascular Journal: Scj 38(3): 172-177

Ol'binskaia, L.I.; Ignatenko, S.B.; Markin, S.S. 2003: Tumor necrosis factor in blood plasma and morphofunctional parameters of the hart in patients with chronic heart failure complicated by a course of ischemic heart disease. Dynamics under effect of treatment. Terapevticheskii Arkhiv 75(2): 54-58

Thirumalaikolundusubramanian, P. 1997: Tumor necrosis factor in falciparum malaria. Annals of Saudi Medicine 17(5): 566-567

Shirasaki, H.; Kanaizumi, E.; Watanabe, K.; Konno, N.; Sato, J.; Narita, S-Ichirou.; Himi, T. 2003: Tumor necrosis factor increases MUC1 mRNA in cultured human nasal epithelial cells. Acta Oto-Laryngologica 123(4): 524-531

Deepe, G.S.; Smelt, S.; Louie, J.S. 2005: Tumor necrosis factor inhibition and opportunistic infections. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(Suppl 3): S187-S188

Sweiss, N.J.; Welsch, M.Jude.; Curran, J.J.; Ellman, M.H. 2005: Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis and Rheumatism 53(5): 788-791

Zhu, Z.; Stevenson, D.; Schechter, J.E.; Mircheff, A.K.; Crow, R.W.; Atkinson, R.; Ritter, T.; Bose, S.; Trousdale, M.D. 2003: Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis. Cornea 22(4): 343-351

Tagawa, T.; Kozower, B.D.; Kanaan, S.A.; Daddi, N.ò; Suda, T.; Oka, T.; Patterson, G.A. 2003: Tumor necrosis factor inhibitor gene transfer ameliorates lung graft ischemia-reperfusion injury. Journal of Thoracic and Cardiovascular Surgery 126(4): 1147-1154

Giles, J.T.; Bartlett, S.J.; Gelber, A.C.; Nanda, S.; Fontaine, K.; Ruffing, V.; Bathon, J.M. 2006: Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis and Rheumatism 55(2): 333-337

Naguwa, S.M. 2005: Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Annals of the new York Academy of Sciences 1051: 709-715

Heymann, W.R. 2007: Tumor necrosis factor inhibitor-induced pustular psoriasis?. Journal of the American Academy of Dermatology 56(2): 327-329

Roos, J.C.; Ostor, A.J. 2006: Tumor necrosis factor inhibitors for rheumatoid arthritis. New England Journal of Medicine 355(19): 2046-2047

Sawitzke, A.; Clegg, D.O. 2003: Tumor necrosis factor inhibitors "SPARCC" an interest in consensus. Journal of Rheumatology 30(6): 1127-1129

Anderson, P.J. 2005: Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles. Seminars in Arthritis and Rheumatism 34(5 Suppl 1): 19-22

White, B. 2005: Tumor necrosis factor inhibitors: following best practice. Managed Care 14(5 Suppl): 17-23

Luo, Y.; Berman, M.A.; Abromson-Leeman, S.R.; Dorf, M.E. 2003: Tumor necrosis factor is required for RANTES-induced astrocyte monocyte chemoattractant protein-1 production. Glia 43(2): 119-127

Hsu, H.-C.; Wu, Y.; Mountz, J.D. 2006: Tumor necrosis factor ligand-receptor superfamily and arthritis. Current Directions in Autoimmunity 9: 37-54

Suzuki, J.-I.; Cole, S.E.; Batirel, S.; Kosuge, H.; Shimizu, K.; Isobe, M.; Libby, P.; Mitchell, R.N. 2003: Tumor necrosis factor receptor -1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 3(8): 968-976

Yu, X.W.; Yan, C.F.; Jin, H.; Li, X. 2005: Tumor necrosis factor receptor 1 expression and early spontaneous abortion. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 88(1): 44-48

Yousaf, N.; Gould, D.J.; Aganna, E.; Hammond, L.; Mirakian, R.M.; Turner, M.D.; Hitman, G.A.; McDermott, M.F.; Chernajovsky, Y. 2005: Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis and Rheumatism 52(9): 2906-2916

Constantin, A.; Dieudé, P.; Lauwers-Cancès, Vérie.; Jamard, Bénédicte.; Mazières, B.; Cambon-Thomsen, A.; Cornélis, Fçois.; Cantagrel, A. 2004: Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis and Rheumatism 50(3): 742-747

Alvarez-Lobos, M.; Hunter, B.; Cofré, C.; Benítez, C.; Talesnik, E.; Oyarzo, M.; Aróstegui, J.I.; Yagüe, J. 2006: Tumor necrosis factor receptor associated periodic syndrome (TRAPS). Report of two cases. Revista Medica de Chile 134(12): 1558-1561

Deng, G.-M. 2007: Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 21(1): 23-29

Kotani, J.; Avallone, N.J.; Lin, E.; Goshima, M.; Lowry, S.F.; Calvano, S.E. 2006: Tumor necrosis factor receptor regulation of bone marrow cell apoptosis during endotoxin-induced systemic inflammation. Shock 25(5): 464-471

Hentgen, V.; Granel, B.; Dodé, C.; Cuisset, L.; Delpech, M.; Grateau, G. 2003: Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS). La Revue de Medecine Interne 24(12): 781-785

Hoshino, S.; Ouchi, Y. 2004: Tumor necrosis factor receptor(TNFR) gene polymorphism. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 173-177

Fotin-Mleczek, M.; Henkler, F.; Hausser, A.; Glauner, H.; Samel, D.; Graness, A.; Scheurich, P.; Mauri, D.; Wajant, H. 2004: Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. Journal of Biological Chemistry 279(1): 677-685

Masson, C.; Simon, V.; Hoppé, E.; Insalaco, P.; Cissé, I.; Audran, M. 2004: Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 71(4): 284-290

Kriegel, M.A.; Hüffmeier, U.; Scherb, E.; Scheidig, C.; Geiler, T.; Kalden, J.R.; Reis, Aé.; Lorenz, H-Martin. 2003: Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis. Arthritis and Rheumatism 48(8): 2386-2388

Manki, A.; Nishikomori, R.; Nakata-Hizume, M.; Kunitomi, T.; Takei, S.; Urakami, T.; Morishima, T. 2006: Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. Allergology International: Official Journal of the Japanese Society of Allergology 55(3): 337-341

Kieszko, R.; Krawczyk, Pł.; Chocholska, S.; Bojarska-Junak, A.; Jankowska, O.; Król, A.; Roliński, J.; Milanowski, J. 2007: Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Respiratory Medicine 101(3): 645-654

Patrizio, M. 2004: Tumor necrosis factor reduces cAMP production in rat microglia. Glia 48(3): 241-249

He, S.-q.; Chen, X.-p.; Zhang, W.-g.; Wang, H.-p.; Wang, Q. 2004: Tumor necrosis factor related apoptosis-inducing ligand induces apoptosis and sensitizes resistant hepatic cancer cells to chemotherapy. Zhonghua Gan Zang Bing Za Zhi 12(8): 456-459

Mocellin, S.; Rossi, C.R.; Pilati, P.; Nitti, D. 2005: Tumor necrosis factor, cancer and anticancer therapy. Cytokine and Growth Factor Reviews 16(1): 35-53

Andersson By, U.; Tani, E.; Andersson, U.; Henter, J-Inge. 2004: Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. Journal of Pediatric Hematology/Oncology 26(11): 706-711

Dai, C.-Y.; Chuang, W.-L.; Chang, W.-Y.; Chen, S.-C.; Lee, L.-P.; Hsieh, M.-Y.; Hou, N.-J.; Lin, Z.-Y.; Huang, J.-F.; Hsieh, M.-Y.; Wang, L.-Y.; Yu, M.-L. 2006: Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. Journal of Infectious Diseases 193(1): 98-101

Yoshizumi, T.; Yonemitsu, Y.; Ikeda, Y.; Kaneda, Y.; Yanaga, K.; Sugimachi, K.; Sueishi, K. 2006: Tumor necrosis factor-a antisense transfer remarkably improves hepatic graft viability. Liver International: Official Journal of the International Association for the Study of the Liver 26(4): 451-456

Dutz, J.P. 2007: Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy?. Journal of Rheumatology 34(2): 247-249

Sakumoto, R.; Shibaya, M.; Okuda, K. 2003: Tumor necrosis factor-alpha (TNF alpha) inhibits progesterone and estradiol-17beta production from cultured granulosa cells: presence of TNFalpha receptors in bovine granulosa and theca cells. Journal of Reproduction and Development 49(6): 441-449

Dumon, K.; Rossbach, C.; Harms, B.; Gorelov, V.; Gross-Weege, W.; Schneider, E.M.; Goretzki, P.E.; Röher, H.D. 1998: Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism in surgical intensive care patients with SIRS. Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 387-390

Leonardi, A.; Brun, P.; Tavolato, M.; Plebani, M.; Abatangelo, G.; Secchi, A.G. 2003: Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis. European Journal of Ophthalmology 13(7): 606-610

Hänninen, K.; Katila, H.; Rontu, R.; Mattila, K.M.; Hurme, M.; Lehtimäki, T. 2005: Tumor necrosis factor-alpha --G308A polymorphism in schizophrenia in a Finnish population. Neuroscience Letters 385(1): 76-81

Rodríguez-Carreón, A.Angelica.; Zúñiga, Jín.; Hernández-Pacheco, G.; Rodríguez-Pérez, Jé.Manuel.; Pérez-Hernández, N.; Montes de Oca, J.Vicente.; Cardiel, M.H.; Granados, J.; Vargas-Alarcón, G. 2005: Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. Journal of Autoimmunity 24(1): 63-68

Lio, D.; Annoni, G.; Licastro, F.; Crivello, A.; Forte, G.I.; Scola, L.; Colonna-Romano, G.; Candore, G.; Arosio, B.; Galimberti, L.; Vergani, C.; Caruso, C. 2006: Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mechanisms of Ageing and Development 127(6): 567-571

Krayenbuehl, P.-A.; Maly, F.E.; Hersberger, M.; Wiesli, P.; Himmelmann, A.; Eid, K.; Greminger, P.; Vetter, W.; Schulthess, G. 2006: Tumor necrosis factor-alpha -308G>A allelic variant modulates iron accumulation in patients with hereditary hemochromatosis. Clinical Chemistry 52(8): 1552-1558

Todorov, V.T.; Völkl, S.; Müller, M.; Bohla, A.; Klar, J.ür.; Kunz-Schughart, L.A.; Hehlgans, T.; Kurtz, A. 2004: Tumor necrosis factor-alpha activates NFkappaB to inhibit renin transcription by targeting cAMP-responsive element. Journal of Biological Chemistry 279(2): 1458-1467

Gerlo, S.; Verdood, P.; Kooijman, R. 2006: Tumor necrosis factor-alpha activates the extrapituitary PRL promoter in myeloid leukemic cells. Journal of Neuroimmunology 172(1-2): 206-210

Friedrichsen, S.ön.; Harper, C.V.; Semprini, S.; Wilding, M.; Adamson, A.D.; Spiller, D.G.; Nelson, G.; Mullins, J.J.; White, M.R.H.; Davis, J.R.E. 2006: Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling. Endocrinology 147(2): 773-781

Morales, V.; Gonzalez-Robayna, I.; Santana, M.P.; Hernandez, I.; Fanjul, L.F. 2006: Tumor necrosis factor-alpha activates transcription of inducible repressor form of 3',5'-cyclic adenosine 5'-monophosphate-responsive element binding modulator and represses P450 aromatase and inhibin alpha-subunit expression in rat ovarian granulosa cells by a p44/42 mitogen-activated protein kinase-dependent mechanism. Endocrinology 147(12): 5932-5939

Laskov, R.; Berger, N.; Scharff, M.D.; Horwitz, M.S. 2006: Tumor necrosis factor-alpha and CD40L modulate cell surface morphology and induce aggregation in Ramos Burkitt's lymphoma cells. Leukemia and Lymphoma 47(3): 507-519

Vavricka, S.R.; Musch, M.W.; Fujiya, M.; Kles, K.; Chang, L.; Eloranta, J.J.; Kullak-Ublick, G.A.; Drabik, K.; Merlin, D.; Chang, E.B. 2006: Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/bbe and in mouse intestine. Pflugers Archiv: European Journal of Physiology 452(1): 71-80

Duggan, E.; Caraher, E.; Gately, K.; O'Dwyer, M.; McGovern, E.; Kelleher, D.; McManus, R.; Ryan, T. 2006: Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery. Critical Care Medicine 34(8): 2134-2139

Kim, T.H.; Kim, B.G.; Shin, H.D.; Kim, J.W.; Kim, C.G.; Kim, J.S.; Jung, H.C.; Song, I.S. 2003: Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Korean Journal of Gastroenterology 42(5): 377-386

Hsu, T.-R.; Chen, S.-J.; Wu, T.-C.; Chung, R.-L.; Tang, R.-B. 2005: Tumor necrosis factor-alpha and interleukin-10 in viral and bacterial gastroenteritis in children. Journal of the Chinese Medical Association: Jcma 68(6): 250-253

Kim, K.-y.; Kim, H.Y.; Kim, J.H.; Lee, C.-H.; Kim, D.-H.; Lee, Y.H.; Han, S.H.; Lim, J.-S.; Cho, D.H.; Lee, M.-S.; Yoon, S.; Kim, K.I.; Yoon, D.-Y.; Yang, Y. 2006: Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. Febs Letters 580(16): 3953-3960

Lockwood, C.J.; Arcuri, F.; Toti, P.; Felice, C.D.; Krikun, G.; Guller, S.; Buchwalder, L.F.; Schatz, F. 2006: Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. American Journal of Pathology 169(4): 1294-1302

Astakhin, A.V.; Levitan, B.N.; Afanas'ev, S.S.; Vorob'ev, A.A.; Aleshkin, V.A.; Dudina, O.S. 2004: Tumor necrosis factor-alpha and interleukin-4 in the blood sera of chronic hepatitis patients. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 46-50

Bessis, A.; Bernard, D.; Triller, A. 2005: Tumor necrosis factor-alpha and neuronal development. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 11(4): 277-281

Christopher-Stine, L.; Wigley, F. 2003: Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease. Journal of Rheumatology 30(12): 2725-2727

Akobeng, A.K.; Zachos, M. 2004: Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 1: Cd003574

Kotyla, P.J.; Sliwinska-Kotyla, B.; Kucharz, E.J. 2006: Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin. Journal of rheumatology 33(11): 2361-3; author reply 2363

Brouckaert, P.; Takahashi, N.; van Tiel, S.T.; Hostens, J.; Eggermont, A.M.M.; Seynhaeve, A.L.B.; Fiers, W.; ten Hagen, T.L.M. 2004: Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics. International Journal of Cancer 109(3): 442-448

Guillevin, L.ïc.; Mouthon, L. 2004: Tumor necrosis factor-alpha blockade and the risk of vasculitis. Journal of Rheumatology 31(10): 1885-1887

Van den Bosch, F.; De Keyser, F.; Mielants, H.; Veys, E.M. 2005: Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?. Arthritis Research and Therapy 7(3): 121-123

Menon, C.; Ghartey, A.; Canter, R.; Feldman, M.; Fraker, D.L. 2006: Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin. Annals of Surgery 244(5): 781-791

Dawn, B.; Guo, Y.; Rezazadeh, A.; Wang, O.-L.; Stein, A.B.; Hunt, G.; Varma, J.; Xuan, Y.-T.; Wu, W.-J.; Tan, W.; Zhu, X.; Bolli, R. 2004: Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. Journal of Molecular and Cellular Cardiology 37(1): 51-61

Wen, Y.; Wang, J.-y.; Liu, P. 2003: Tumor necrosis factor-alpha enhances the effect of endothelin on renal vasoconstriction in isolated perfused rat kidney. Zhonghua Gan Zang Bing Za Zhi 11(10): 583-585

Maxey, T.S.; Enelow, R.I.; Gaston, B.; Kron, I.L.; Laubach, V.E.; Doctor, A. 2004: Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. Journal of thoracic and cardiovascular surgery 127(2): 541-547

Soga, Y.; Nishimura, F.; Ohyama, H.; Maeda, H.; Takashiba, S.; Murayama, Y. 2003: Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. Journal of Clinical Periodontology 30(6): 524-531

Antonicelli, R.; Olivieri, F.; Cavallone, L.; Spazzafumo, L.; Bonafè, M.; Marchegiani, F.; Cardelli, M.; Galeazzi, R.; Giovagnetti, S.; Perna, G.P.; Franceschi, C. 2005: Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coronary Artery Disease 16(8): 489-493

Chen, D.; Hu, Y.; Wu, B.; Chen, L.; Fang, Z.'a.; Yang, F.; Wang, L. 2003: Tumor necrosis factor-alpha gene G308A polymorphism is associated with the risk of preterm delivery. Beijing da Xue Xue Bao. Yi Xue Ban 35(4): 377-381

Hoffmann, G.; Schloesser, M.; Czechowski, M.; Schobersberger, W.; Fürhapter, C.; Sepp, N. 2004: Tumor necrosis factor-alpha gene expression and release in cultured human dermal microvascular endothelial cells. Experimental Dermatology 13(2): 113-119

Pae, C.-U.; Chae, J.-H.; Bahk, W.-M.; Han, H.; Jun, T.-Y.; Kim, K.-S.; Kwon, Y.-S.; Serretti, A. 2003: Tumor necrosis factor-alpha gene polymorphism at position -308 and schizophrenia in the Korean population. Psychiatry and Clinical Neurosciences 57(4): 399-403

Xiang, P.-X.; Li, Y.; Zhang, P.-A. 2004: Tumor necrosis factor-alpha gene polymorphisms and risk of coronary heart disease. Yi Chuan 26(6): 807-810

Somi, M.H.; Najafi, L.; Noori, B.N.; Alizadeh, A.H.M.; Aghah, M.R.; Shavakhi, A.; Ehsani, M.J.; Aghazadeh, R.; Masoodi, M.; Amini, S.; Baladast, M.; Zali, M.R. 2006: Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(1): 14-15

Celebi Kobak, A.; Kobak, S.; Kabasakal, Y.; Akarca, U.S. 2007: Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clinical Rheumatology 26(6): 908-910

Chierakul, N.; Wongwisutikul, P.; Vejbaesya, S.; Chotvilaiwan, K. 2005: Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 10(1): 36-39

Charakida, M.; Halcox, J.Pj. 2005: Tumor necrosis factor-alpha in heart failure: more questions than answers. Revista Espanola de Cardiologia 58(5): 470-472

Kast, R.E.; Altschuler, E.L. 2003: Tumor necrosis factor-alpha in hepatitis B: potential role for bupropion. Journal of Hepatology 39(1): 131-133

Efthimiou, P. 2006: Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications. Seminars in Arthritis and Rheumatism 36(3): 168-172

Bilenko, M.V.; Khil'chenko, A.V.; Shmit'ko, N.A. 2003: Tumor necrosis factor-alpha in low doses preactivates and activates macrophages by increasing their ability to produce reactive oxygen species and oxidize low-density lipoproteins: protective effect of antioxidants. Bulletin of Experimental Biology and Medicine 135(4): 349-352

Odeh, M.; Oliven, A. 2005: Tumor necrosis factor-alpha in parapneumonic effusion. Chest 127(5): 1868; Author Reply 1868-9

Kane, D.; FitzGerald, O. 2004: Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Current Rheumatology Reports 6(4): 292-298

Beckmann, I.; Efraim, S.B.; Vervoort, M.; Visser, W.; Wallenburg, H.C.S. 2004: Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertension in Pregnancy 23(3): 319-329

Song, H.-L.; Lu, S.; Liu, P. 2005: Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure. World Journal of Gastroenterology 11(24): 3701-3709

Kwak, H.B.; Jin, H.-M.; Ha, H.; Kang, M.-J.; Lee, S.B.; Kim, H.-H.; Lee, Z.H. 2005: Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1). Biochemical and Biophysical Research Communications 330(4): 1080-1086

Liu, Y.-L.; Zhou, L.-J.; Hu, N.-W.; Xu, J.-T.; Wu, C.-Y.; Zhang, T.; Li, Y.-Y.; Liu, X.-G. 2007: Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 52(3): 708-715

Wang, Y.; Tao, J.; Yang, Z.; Tu, C.; Xu, M-guo.; Wang, J-mei.; Huang, Y-jun. 2005: Tumor necrosis factor-alpha induces release of endothelial microparticles from human endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi 33(12): 1137-1140

Sullivan, D.E.; Ferris, M.; Pociask, D.; Brody, A.R. 2005: Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. American Journal of Respiratory Cell and Molecular Biology 32(4): 342-349

Bosello, S.; De Santis, M.; Tolusso, B.; Zoli, A.; Ferraccioli, G. 2005: Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis. Annals of Internal Medicine 143(12): 918-920

Anderson, H.D.I.; Rahmutula, D.; Gardner, D.G. 2004: Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. Journal of Biological Chemistry 279(2): 963-969

Sung, C.K.; She, H.; Xiong, S.; Tsukamoto, H. 2004: Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 286(5): G722-G729

Niemann, J.T.; Garner, D.; Lewis, R.J. 2004: Tumor necrosis factor-alpha is associated with early postresuscitation myocardial dysfunction. Critical Care Medicine 32(8): 1753-1758

Yano, Y.; Gabazza, E.C.; Kitagawa, N.; Bruno, N.E.; Matsumoto, K.; Nakatani, K.; Araki, R.; Katsuki, A.; Adachi, Y.; Sumida, Y. 2004: Tumor necrosis factor-alpha is associated with increased protein C activation in nonobese type 2 diabetic patients. Diabetes Care 27(3): 844-845

Ahn, S.-Y.; Jang, G.-C.; Shin, J.-S.; Shin, K.M.; Kim, D.-S. 2003: Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Medical Journal 44(6): 1021-1026

Karacay, S.; Saygun, I.şi.; Bengi, A.O.; Serdar, M. 2007: Tumor necrosis factor-alpha levels during two different canine distalization techniques. Angle Orthodontist 77(1): 142-147

Wig, N.; Anupama, P.; Singh, S.; Handa, R.; Aggarwal, P.; Dwivedi, S.N.; Jailkhani, B.L.; Wali, J.P. 2005: Tumor necrosis factor-alpha levels in patients with HIV with wasting in South Asia. Aids Patient Care and Stds 19(4): 212-215

Jagger, C.J.; Lean, J.M.; Davies, J.T.; Chambers, T.J. 2005: Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. Endocrinology 146(1): 113-118

Agrawal, C.; Raghav, S.Kumar.; Gupta, B.; Das, R.Hari.; Chaturvedi, V.Prakash.; Goswami, K.; Das, H.Rani. 2005: Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Archives of Medical Research 36(5): 555-559

Alikasifoglu, M.; Tokgözoglu, L.; Acil, T.; Atalar, E.; Ali Oto, M.; Sirri Kes, S.ül.; Tuncbilek, E.ül. 2003: Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy. European Journal of Heart Failure 5(2): 161-163

Pan, C.-h.; Luo, R.-c. 2003: Tumor necrosis factor-alpha pretreatment for in vitro culture of mature dendritic cells. Di 1 Jun Yi da Xue Xue Bao 23(2): 114-117

Khoa, N.D.; Postow, M.; Danielsson, J.; Cronstein, B.N. 2006: Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Molecular Pharmacology 69(4): 1311-1319

Lee, Y.H.; Ji, J.D.; Song, G.G. 2007: Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. Journal of Rheumatology 34(1): 43-49

Wu, Y.-R.; Feng, I.-H.; Lyu, R.-K.; Chang, K.-H.; Lin, Y.-Y.; Chan, H.; Hu, F.-J.; Lee-Chen, G.-J.; Chen, C.-M. 2007: Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson's disease. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 144b (3): 300-304

Jazrawi, S.F.; Zaman, A.; Muhammad, Z.; Rabkin, J.M.; Corless, C.L.; Olyaei, A.; Biggs, A.; Ham, J.; Chou, S.; Rosen, H.R. 2003: Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 9(4): 377-382

Papakonstanti, E.A.; Stournaras, C. 2004: Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Molecular Biology of the Cell 15(3): 1273-1286

Mikhaylova, I.V.; Kuulasmaa, T.; Jääskeläinen, J.; Voutilainen, R. 2007: Tumor necrosis factor-alpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R. Endocrinology 148(1): 386-392

Nasu, K.; Itoh, H.; Yuge, A.; Nishida, M.; Kawano, Y.; Narahara, H. 2007: Tumor necrosis factor-alpha regulates vascular endothelial growth factor secretion by human oviductal epithelial cells and stromal fibroblasts. Fertility and Sterility 87(1): 220-222

Vecchiarelli, A.; Puliti, M.; Blasi, E.; Bistoni, F. 1989: Tumor necrosis factor-alpha secretion by splenocytes of Candida albicans infected mice. Journal of ChemoTherapy 1(4 Suppl): 1170-1171

Luo, J.C.; Shin, V.Y.; Yang, Y.H.; Wu, W.K.K.; Ye, Y.N.; So, W.H.L.; Chang, F.Y.; Cho, C.H. 2005: Tumor necrosis factor-alpha stimulates gastric epithelial cell proliferation. American Journal of Physiology. Gastrointestinal and Liver Physiology 288(1): G32-G38

Bowen, E.J.; Schmidt, T.W.; Firm, C.S.; Russo, A.F.; Durham, P.L. 2006: Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. Journal of Neurochemistry 96(1): 65-77

Lora, J.é M.; Zhang, D.M.; Liao, S.M.; Burwell, T.; King, A.M.; Barker, P.A.; Singh, L.; Keaveney, M.; Morgenstern, J.; Gutiérrez-Ramos, J.é C.; Coyle, A.J.; Fraser, C.C. 2005: Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. Journal of Biological Chemistry 280(43): 36510-36517

García-Vallejo, J.J.ús.; van Dijk, W.; van Die, I.; Gringhuis, S.I. 2005: Tumor necrosis factor-alpha up-regulates the expression of beta1,4-galactosyltransferase i in primary human endothelial cells by mRNA stabilization. Journal of Biological Chemistry 280(13): 12676-12682

Wang, Y.-m.; Feng, G.-h.; Huang, F.; Li, Y.; Zhao, G.-z. 2003: Tumor necrosis factor-alpha, caspase-3 expression and hepatocyte apoptosis in fulminanting hepatic failure. Zhonghua Nei Ke Za Zhi 42(8): 566-570

Andrade, C. 2004: Tumor necrosis factor-alpha, depression, and ECT: toward a better understanding of the relationships. Journal of Ect 20(3): 197-198

Krebs, V.L.úc.J.; Okay, T.S.; Okay, Y.; Vaz, F.áv.A.C. 2005: Tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 in the cerebrospinal fluid of newborn with meningitis. Arquivos de Neuro-Psiquiatria 63(1): 7-13

Prieto, I.; Jiménez, F.; Aller, M.-A.; Nava, M.-P.; Vara, E.; Garcia, C.; Arias, J. 2005: Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats. World Journal of Surgery 29(7): 903-908

Zhu, Y.; Osterlundh, I.; Hultén, F.; Magnusson, U. 2004: Tumor necrosis factor-alpha, interleukin-6, serum amyloid A, haptoglobin, and cortisol concentrations in sows following intramammary inoculation of Escherichia coli. American Journal of Veterinary Research 65(10): 1434-1439

Achrol, A.S.; Pawlikowska, L.; McCulloch, C.E.; Poon, K.Y.T.; Ha, C.; Zaroff, J.G.; Johnston, S.C.; Lee, C.; Lawton, M.T.; Sidney, S.; Marchuk, D.A.; Kwok, P.-Y.; Young, W.L. 2006: Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37(1): 231-234

Tsakadze, N.L.; Sithu, S.D.; Sen, U.; English, W.R.; Murphy, G.; D'Souza, S.E. 2006: Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). Journal of Biological Chemistry 281(6): 3157-3164

Cruz, A.C.; Frank, B.T.; Edwards, S.T.; Dazin, P.F.; Peschon, J.J.; Fang, K.C. 2004: Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. Journal of Biological Chemistry 279(7): 5612-5620

Kurz, M.; Pischel, H.; Hartung, H.-P.; Kieseier, B.C. 2005: Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. Journal of the Peripheral Nervous System: Jpns 10(3): 311-318

Kojima, M.; Sekikawa, K.; Nemoto, K.; Degawa, M. 2005: Tumor necrosis factor-alpha-independent downregulation of hepatic cholesterol 7alpha-hydroxylase gene in mice treated with lead nitrate. Toxicological Sciences: An Official Journal of the Society of Toxicology 87(2): 537-542

Vestergaard, C.; Johansen, C.; Otkjaer, K.; Deleuran, M.; Iversen, L. 2005: Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine 29(2): 49-55

Carlson, D.L.; Willis, M.S.; White, D.J.; Horton, J.W.; Giroir, B.P. 2005: Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Critical Care Medicine 33(5): 1021-1028

Handa, O.; Naito, Y.; Takagi, T.; Shimozawa, M.; Kokura, S.; Yoshida, N.; Matsui, H.; Cepinskas, G.; Kvietys, P.R.; Yoshikawa, T. 2004: Tumor necrosis factor-alpha-induced cytokine-induced neutrophil chemoattractant-1 (CINC-1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor-kappaB. Journal of Pharmacology and Experimental Therapeutics 309(2): 670-676

Lin, M.C.; Lee, N.P.; Zheng, N.; Yang, P.-H.; Wong, O.G.; Kung, H.-F.; Hui, C.-K.; Luk, J.M.; Lau, G.K.-K. 2005: Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus. World Journal of Gastroenterology 11(48): 7564-7568

Bredel, M.; Bredel, C.; Juric, D.; Duran, G.E.; Yu, R.X.; Harsh, G.R.; Vogel, H.; Recht, L.D.; Scheck, A.C.; Sikic, B.I. 2006: Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(2): 274-287

Little, Fédéric.F.; Lynch, E.; Fine, G.; Center, D.M.; Cruikshank, W.W. 2003: Tumor necrosis factor-alpha-induced synthesis of interleukin-16 in airway epithelial cells: priming for serotonin stimulation. American Journal of Respiratory Cell and Molecular Biology 28(3): 354-362

Kalambokis, G.; Kostoula, A.; Economou, M.; Tsianos, E.V. 2005: Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites. Clinical Chemistry 51(11): 2207-2208

Radeff-Huang, J.; Seasholtz, T.M.; Chang, J.W.; Smith, J.M.; Walsh, C.T.; Brown, J.H. 2007: Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. Journal of Biological Chemistry 282(2): 863-870

Eggermont, A.M.M.; ten Hagen, T.L.M. 2003: Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy. Current oncology reports 5(2): 79-80

Lu, L.-Y.; Cheng, H.-H.; Sung, P.-K.; Tai, M.-H.; Yeh, J.-J.; Chen, A. 2005: Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. Journal of the Formosan Medical Association 104(8): 563-570

Dogra, C.; Changotra, H.; Mohan, S.; Kumar, A. 2006: Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. Journal of Biological Chemistry 281(15): 10327-10336

Schmidt, O.I.; Morganti-Kossmann, M.C.; Heyde, C.E.; Perez, D.; Yatsiv, I.; Shohami, E.; Ertel, W.; Stahel, P.F. 2004: Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. Journal of Neuroinflammation 1(1): 13

Straub, R.H.; Härle, P.; Sarzi-Puttini, P.; Cutolo, M. 2006: Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis and Rheumatism 54(7): 2039-2046

Chen, Z.; Wang, H.; Gu, L.; Ye, Z.; Xiao, Y. 2005: Tumor necrosis factor-related apoptosis ligand induces apoptosis in prostate cancer PC-3M cell line. Journal of Huazhong University of Science and Technology. Medical Sciences 25(4): 442

Yamaguchi, Y.; Shiraki, K.; Saitou, Y.; Nakano, T.; Mizuno, S.; Uemoto, S. 2004: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) during liver regeneration. Journal of Hepatology 40(4): 718-719

Ständer, S.; Schwarz, T. 2005: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed in normal skin and cutaneous inflammatory diseases, but not in chronically UV-exposed skin and non-melanoma skin cancer. American Journal of Dermatopathology 27(2): 116-121

Ballestrero, A.; Nencioni, A.; Boy, D.; Rocco, I.; Garuti, A.; Mela, G.Sandro.; Van Parijs, L.; Brossart, P.; Wesselborg, S.; Patrone, F. 2004: Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(4): 1463-1470

Xu, X.-M.; He, C.; Hu, X.-T.; Fang, B.-L. 2003: Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29. World Journal of Gastroenterology 9(5): 965-969

De Vries, E.G.E.; Gietema, J.A.; de Jong, S. 2006: Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(8): 2390-2393

Sinicrope, F.A.; Penington, R.C.; Tang, X.M. 2004: Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(24): 8284-8292

Jaganathan, J.; Petit, J.H.; Lazio, B.E.; Singh, S.K.; Chin, L.S. 2002: Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines. Neurosurgical Focus 13(3): Ecp1

Menendez, L.R.; Ahlmann, E.R.; Savage, K.; Cluck, M.; Fedenko, A.N. 2007: Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma. Clinical Orthopaedics and Related Research 455: 219-224

Hendershot, E.; Pappo, A.; Malkin, D.; Sung, L. 2006: Tumor necrosis in pediatric osteosarcoma: impact of modern therapies. Journal of Pediatric Oncology Nursing: Official Journal of the Association of Pediatric Oncology Nurses 23(4): 176-181

Charpin, C.; Dales, J.-P.; Garcia, S.ép.; Carpentier, S.év.; Djemli, A.; Andrac, L.; Lavaut, M.-N.ël.; Allasia, C.; Bonnier, P. 2004: Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(17): 5815-5819

Risley, S.D. 1896: Tumor of Optic Nerve and Retina. Transactions of the American Ophthalmological Society 7: 526-530

Bischler, V.; Chodos, J.B. 1957: Tumor of Rathke's pouch evolving for 50 years. Revue D'oto-Neuro-Ophtalmologie 29(3): 183-186

Razemon, P.; Fovet, A.; Guerrin, F. 1961: Tumor of Vater's ampulla treated by total duodenectomy, cephalic pancreatectomy and resection of the 1st jejunal loop. Archives des Maladies de l'Appareil Digestif et des Maladies de la Nutrition 50: 376-379

Schober, K.L. 1955: Tumor of a horse-shoe kidney with a unilateral malformation of the renal pelvis. Zeitschrift für Urologie 48(7): 457-458

Labail, G.; Fontan, F.; Sentucq, M. 1955: Tumor of amebic origin in the right iliac fossa. Bordeaux Chirurgical 3: 141-143

Poppen, J.L.; Riemenschneider, P.A. 1951: Tumor of carotid body type presumably arising from the glomus jugularis. A.M.A. Archives of Otolaryngology 53(4): 453-459

Huguenin, A.; Bourgeon, R.; Miniconi, P. 1952: Tumor of cecum of amebic origin; excision and ileotransversostomy. Algerie Medicale 56(8): 494-501

Dogan, S.; Kozic, M. 1955: Tumor of cerebellum. Neuropsihijatrija 3(3-4): 269-270

Bret, J.; Vassy, S.; Nuovo, V. 1950: Tumor of fallopian tube and vaginal smears. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 2(4): 411-413

Klier, E. 1952: Tumor of granulation tissue appearing as hernia discovered after old covered perforation of small intestine. Zentralblatt für Chirurgie 77(47): 2309-2311

Bac, E.; Nikulin, A. 1956: Tumor of jugular glomus. Medicinski Arhiv 10(2): 75-80

Fassio, E. 1956: Tumor of left hypochondrium with febrile pseudomalarial attacks. Archives des Maladies de l'Appareil Digestif et des Maladies de la Nutrition 45(12): 552

Leroux-Robert; Metzger; Peuteuil, G.; Thierree, R.A. 1956: Tumor of mid-facial tissues. Journal de Radiologie d'Electrologie and Archives d'Electricite Medicale 37(9-10): 826-827

Israel, R.; Hertzog, P.; Uzzan, D.; Gilbert, J. 1956: Tumor of neurinomatous type almost entirely enveloped in a pulmonary fissure. Journal Francais de Medecine et Chirurgie Thoraciques 10(2): 230-231

Thurel, R. 1950: Tumor of occipital foramen and syringomyelobulbia. Revue Neurologique (Paris) 82(5): 396-397

Bessiere, E.; Monod, F.; Verin, P. 1957: Tumor of optic papilla and Alsberg's circumscribed multiple lipomatosis. Bulletin des Societes d'Ophtalmologie de France 9: 607-609

Tebbett, R.D. 1949: Tumor of orbit. American Journal of Ophthalmology 32(12): 1751-1753

Kulvin, M.M.; Sawchak, W.G. 1960: Tumor of orbit metastatic from malignant bronchial adenoma. American Journal of Ophthalmology 49: 833-838

Ferey, D.; Ferey, J.; Chevrel, M.L.; Beltan, M.; Beltan, A.; Richier, J.; Richier, M.E. 1955: Tumor of pituitary region with seminoma structure (seminoma carcinoma-like). Revue Neurologique (Paris) 92(1): 76-80

Brosch, W. 1956: Tumor of right kidney in 56 year old man of the size of a child's head, tubular carcinoma. Zeitschrift für Urologie 49(1): 55-57

Faber, M.; Gjersoe, A.; Munk-Andersen, G. 1953: Tumor of small intestine. Ugeskrift for Laeger 115(17): 627-632

Quackenboss, A. 1910: Tumor of the Adrenal Gland with Metastasis in the Orbit: Pathologic Examination by Dr. H. F. Verhoeff. Transactions of the American Ophthalmological Society 12(Pt 2): 451-455

Knapp, H. 1879: Tumor of the Optic Nerve. Transactions of the American Ophthalmological Society 2: 557-560

Sweet, W.M. 1918: Tumor of the Orbit, with Extension to Frontal and Temporal Regions, Treated by X-rays. Transactions of the American Ophthalmological Society 16: 204-208

Mikhailichenko, V.A. 1958: Tumor of the adrenal cortex. Problemy Endokrinologii i Gormonoterapii 4(5): 118-120

Nikolaev, O.V.; Belikhova, E.L. 1959: Tumor of the adrenal cortex in a 7-month-old infant. Problemy Endokrinologii i Gormonoterapii 5(1): 94-95

D'halluin, C. 1957: Tumor of the ampulla of Vater; papillectomy; intraduodenal choledoco-duodenostomy; recovery after 17 months. Lille Chirurgical 12(2): 88-93

Sagi, T. 1957: Tumor of the aortic valve. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 96(5-6): 209-211

Nikonova, O.S. 1958: Tumor of the arteriovenous anastomosis of the fingers. Sovetskaia Meditsina 22(2): 118-121

Dor, J.; Pons; Humbert; Aboucaya 1957: Tumor of the base of right lung (spinocellular epithelioma having invaded the diaphragm and adherent to the liver; mass phrenolobar exeresis. Marseille Chirurgical 9(1): 66-67

Mosca, L.G. 1955: Tumor of the base of the right hemithorax. El Dia Medico 27(93): 3113-3116

Babinski, J.P.; Babinski, J.P. 1993: Tumor of the body of the pituitary without acromegaly and with arrest of development of the genital organs. 1900. Obesity Research 1(4): 332-333

Haran, A.M. 1950: Tumor of the breast due to hyperfolliculinemia in hysterectomy with conservation of an ovary. Boletin. Sociedad de Cirugia del Uruguay 21(6): 631-644

Cabanne, F. 1954: Tumor of the broad ligament in a little girl; possible mesonephroma. Bulletin de l'Association Francaise Pour l'Etude du Cancer 41(1): 139-148

Besznyak, I. 1957: Tumor of the carotid body (chemodectoma). Orvosi Hetilap 98(41): 1131-1135

Corbett, A.J.; McCLINTOCK, J.C. 1950: Tumor of the carotid body associated with nodular goiter; report of a case. Archives of Surgery 60(1): 81

Fagarasanu, I.; Gavriliu, D.; Constantinescu, F. 1961: Tumor of the carotid body treated by resection of the carotid bifurcation. Recovery. Memoires. Academie de Chirurgie 87: 790-793

Pikovskii, D.L.; Smetankin, N.I. 1956: Tumor of the carotid body with metastases to a regional lymph node. Vestnik Khirurgii Imeni I. I. Grekova 77(12): 111-113

Dallalana, L.M. 1958: Tumor of the carotid body: case reports. Arquivos Brasileiros de Medicina 48(1-3): 1-42

Leroux-Robert, J.; Reboul, H.; Baron, G. 1953: Tumor of the carotid body; description of auricular functional disturbances, presentation of the arteriographic picture. Les Annales d'Oto-Laryngologie 70(2-3): 154-156

Martorell, F. 1956: Tumor of the carotid body; excision of the tumor with resection of the three carotid arteries, the internal jugular vein and the cervical sympathetic; a fourteen-year cure. Angiology 7(3): 228-232

Weickmann, F. 1954: Tumor of the cauda and papillary stasis; on the problem of the circulation and resorption of the cerebrospinal fluid. Der Nervenarzt 25(2): 65-68

Jentzer, A.; Kessel, K.; Bonnant, M. 1952: Tumor of the cauda equina with papillary stasis. Revue Neurologique (Paris) 87(6): 628-632

Brummelkamp, W.H. 1960: Tumor of the cecum with diverticulosis of the colon. Nederlands Tijdschrift Voor Geneeskunde 104: 23-26

Laine, E.; Fontan, M.; Delandtsheer 1953: Tumor of the central gray nuclei, enlarged total hemispherectomy, postoperative results after four months, and presentation of the patient. Revue Neurologique (Paris) 89(2): 140-145

Louis-Bar, D. 1951: Tumor of the cerebellum. Revue Medicale de Liege 6(16): 520-521

Cecotto, C.; Mingrino, S. 1959: Tumor of the conus and cauda with intracranial hypertension. Acta Chirurgica Italica 15: 977-988

Skoglund, T.S.; Nilsson, D. 2007: Tumor of the conus medullaris treated with antituberculous therapy. Clinical Neurology and Neurosurgery 109(2): 192-194

Querneau, J. 1957: Tumor of the cord. Journal d'Urologie Medicale et Chirurgicale 63(1-2): 101-104

Toya, S.; Fukuda, S.; Hirai, H.; Tanaka, M.; Shimizu, S. 1963: Tumor of the corpus callosum--a case report. No to Shinkei 15: 692-696

Geraud, J.; Lacapere, J.P.; Espagno, J. 1951: Tumor of the cranial vault, metastasis of a latent cancer of the thyroid body. Revue d'Oto-Neuro-Ophtalmologie 23(3): 191-192

Geraud, J.; Lacapere, J.P.; Espagno, J. 1951: Tumor of the cranial vault, metastasis of a latent cancer of the thyroid gland. Toulouse Medical 52(4): 246-249

Heim, G. 1951: Tumor of the craniopharyngeal canal (Erdheim's tumor) manifested by Simmonds' cachexia. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 87(9): 335-336

Lepennetier, F.; Rouquet, F.; Picard, J.M. 1956: Tumor of the fallopian tube. Journal de Radiologie d'Electrologie and Archives d'Electricite Medicale 37(1-2): 48-49

Vianna, E.V. 1955: Tumor of the floor of the mouth. Revista Brasileira de Oto-Rino-Laringologia 23(1): 24-26

Obrador, S.; Boixados, J.R. 1960: Tumor of the foramen lacerum posterius ("hour-glass" shaped). Revista Clinica Espanola 76: 316-318

Lafon, R.; Gros, C.; Labauge, R.; Cadilhac, J.; Minvielle, J.; Paleirac, R.; Vlahovitch, B. 1953: Tumor of the foramen ovale; comparison of anatomical with radiological findings. Journal de Radiologie d'Electrologie and Archives d'Electricite Medicale 34(3-4): 258-260

Poursines, Y.; Gastaut, H.; Gallais, P.; Badier 1953: Tumor of the fourth ventricle choroid papilloma type; ventricular and subarachnoid metastasis. Revue Neurologique (Paris) 88(3): 202-204

Amyot, R.; Lauze, S. 1954: Tumor of the fourth ventricle: histological diagnosis: oligodendroglioma. L'Union Medicale du Canada 83(1): 19-22

Linn, H.J.; Proctor, B. 1956: Tumor of the ganglion nodosum of the vagus nerve. Laryngoscope 66(12): 1577-1581

Pilheu, F.R. 1958: Tumor of the gingiva and pregnancy. La Semana Medica 112(4): 133-136

Pykosz, T. 1954: Tumor of the glomus jugulare. Polski Tygodnik Lekarski 9(7): 193-195

Piscol, K.; Stein, F. 1961: Tumor of the glomus jugulare (tympanicum). Clinical and anatomopathological report. Deutsche Zeitschrift für Nervenheilkunde 183: 105-121

Askenasy, H.M.; Eppenstein, S.S.; Herzberger, E.E. 1953: Tumor of the glomus jugulare co-existing possibly with carotid body tumor. Acta Neurochirurgica 3(2): 170-179

Chambers, W.R. 1954: Tumor of the glomus jugulare resembling brain tumor. Journal of the International College of Surgeons 22(6 Part 1): 691-694

Alexander, E.; Beamer, P.R.; Williams, J.O. 1951: Tumor of the glomus jugulare with extension into the middle ear; nonchromaffin paraganglioma or carotid-body-type tumor. Journal of Neurosurgery 8(5): 515-523

Towson, C.E.; McNELIS, F.J. 1954: Tumor of the glomus jugulare: report of a case. A.M.A. Archives of Otolaryngology 59(2): 152-158

Gerhard, J.P. 1957: Tumor of the glomus jugulare; a case report. Revue d'Oto-Neuro-Ophtalmologie 29(4): 248-250

Alexander, E.; Adams, S. 1953: Tumor of the glomus jugulare; follow-up study two years after roentgen therapy. Journal of Neurosurgery 10(6): 672-674

De Lisa, D.A. 1950: Tumor of the glomus jugularis. Archives of Otolaryngology 51(6): 925-927

Fuller, R.H. 1949: Tumor of the glomus jugularis; report of a case. United States Naval Medical Bulletin 49(6): 1141-4 Illust

Kotorowicz, H. 1957: Tumor of the groin in a child. Pediatria Polska 32(3): 287-288

Cassels, D.E. 1957: Tumor of the heart. Pediatrics 19(1): 162-167

Querneau, J. 1953: Tumor of the horseshoe kidney; heminephrectomy. Journal d'Urologie Medicale et Chirurgicale 59(1-2): 87-90

Bach, E. 1956: Tumor of the hypopharynx eight years after total laryngectomy. Monatsschrift für Ohrenheilkunde und Laryngo-Rhinologie 90(3): 172-174

Algrain, C.; Brandes, J.; Perier, J.O. 1950: Tumor of the hypophysis. Le Scalpel 103(25): 625-630

Kageyama, N.; Waka, S. 1962: Tumor of the hypothalamus. Rinsho Geka. Journal of Clinical Surgery 17: 777-782

Brea, L.M.; Lucano, D.A. 1954: Tumor of the interscrotal septum. Revista Argentina de Urologia 23(9-12): 289-291

Devaux, J. 1951: Tumor of the interstitial gland of the testes in the rabbit. Archives d'Anatomie d'Histologie et d'Embryologie Normales et Experimentales 34(1-8): 175-185

Barre, Y.; Caulet, T.; Dubarry, L. 1962: Tumor of the islands of Langerhans with hyperinsulinism. Archives d'Anatomie Pathologique 10: 64-69

Hermann, M. 1952: Tumor of the jaws in small children. Revue de Stomatologie 53(7): 680-683

Maghenzani, C.L.; Garcia, J.M. 1960: Tumor of the kidney and calcification. Revista Argentina de Urologia 29: 107-111

Dubost, C. 1951: Tumor of the kidney bed explored by retropneumoperitoneum combined with nephrography by means of aortography. Memoires. Academie de Chirurgie 77(35): 1103-1104

Colombo, O. 1953: Tumor of the kidney in children; clinical and histopathological data. Minerva Pediatrica 5(12): 473-476

Rouffilange, F. 1962: Tumor of the kidney with a simple cystic form. Journal d'Urologie et de Nephrologie 68: 431-433

Dotta, J.S.; Delporte, T. 1959: Tumor of the kidney with neoplastic thrombus in the vena cava. Operation with thoracoabdominal approach. Revista Argentina de Urologia 28: 41-45

Brea, L.M.; Lucano, D. 1955: Tumor of the kidney; radiotherapy. Revista Argentina de Urologia 24(4-6): 250-254

Marcel, J.E.; Mozis; Fischgold, H. 1956: Tumor of the kidney; radiotherapy; nephrectomy; late bone metastasis. Archives Francaises de Pediatrie 13(3): 305-315

Irvine, A.R.; Roberts, W.L.; Soulakoff, P.S. 1951: Tumor of the lacrimal gland; report of four cases. American Journal of Ophthalmology 34(11): 1511-1519

Brown, O.A. 1960: Tumor of the lacrimal sac. American Journal of Ophthalmology 49: 1420

Pouyanne, L.; Pouyanne, H.; Guerin, A. 1951: Tumor of the lateral ventricle and bilateral exophthalmos. Revue d'Oto-Neuro-Ophtalmologie 23(7): 425-427

Badaroux, A.; Descuns, P.; Garre, H.; Thevenot, C.; Ramee, A. 1960: Tumor of the left carotid body with multiple intracranial localizations. Revue d'Oto-Neuro-Ophtalmologie 32: 347-350

Mosca, L.G. 1951: Tumor of the left kidney and duodenum. Prensa Medica Argentina 38(6): 323-325

Dubrulle, M. 1953: Tumor of the ligamentum teres hepatis. Acta Chirurgica Belgica 52(8): 827-832

Wills, I.; Jennings, W.K.; Loquvam, G.S.; Russell, W.O. 1950: Tumor of the major duodenal papilla. American Journal of Surgery 80(5): 493-504

Achard, G. 1950: Tumor of the maxilla. Marseille Chirurgical 2(2): 294-295

El-Abdi, B.; Berrkia, I.; Mohssine, A.; El-Hassani, M.R.; El-Quessar, A.; Chakir, N.; Boukhrissi, N.; Jiddane, M. 2006: Tumor of the maxilla presenting as primary hyperparathyroidism. Journal de Radiologie 87(11 Part 1): 1705-1707

Lachapele, A.P.; Biraben, J.; Morvan, A.; Le Roy, H. 1950: Tumor of the mediastinum (anatomo-radiologic study). Journal de Radiologie d'Electrologie and Archives d'Electricite Medicale 31(11-12): 779-780

Sarrouy, C.; Houel, J.; Romeo, R.; Sarrouy, J. 1961: Tumor of the mediastinum simulating Hodgkin's disease. Algerie Medicale 65: 645-647

De All, J.A.; Gene, A.R.; Hammond, H.A.; Zorraquin, L.M. 1960: Tumor of the mediastinum. Brill-Symmers disease. Prensa Medica Argentina 47: 947-953

Alcala-Santaella Nunez, R.; De La Barreda Espinosa, P. 1954: Tumor of the medulla oblongata. Revista Clinica Espanola 52(4): 271-273

Bourrat, L.; Kohler, C. 1951: Tumor of the mesencephalic region in child developing by stages: marked psychomotor instability, cerebellar striatal syndrome, terminal intracranial hypertension. Journal de Medecine de Lyon 32(764): 981-984

Shapkin, V.S. 1954: Tumor of the mesentery of small intestine. Sovetskaia Meditsina 18(2): 32-34

Fleury, P. 1955: Tumor of the nasal fossa; angiohistiocytofibroma. Les Annales d'Oto-Laryngologie 72(11-12): 926-928

Jurkiewicz, D.; Zielnik-Jurkiewicz, B. 2004: Tumor of the neck. Otolaryngologia Polska 58(1): 205-210

Verhaeghe, M.; Clay, A.; Dupont, A.; Demaille, A.; Adenis, L. 1960: Tumor of the nodose ganglion of the pneumogastric nerve. Lille Chirurgical 15: 174-179

Drew, E.J. 1958: Tumor of the omentum simulating portal cirrhosis. Journal. Iowa State Medical Society 48(5): 251-253

Trueman, R.H.; Rubin, I.E. 1953: Tumor of the optic disk associated with neurofibromatosis; presentation of a case. A.M.A. Archives of Ophthalmology 50(4): 468-474

Mecca, M. 1952: Tumor of the optic nerve and Recklinghausen's disease. Annali di Ottalmologia E Clinica Oculistica 78(1): 61-76

Driessens, J.; Francois, J.; Verhaeghe, M.; Cornillot, M.; Petyt, R. 1951: Tumor of the orbit revealing a completely hidden multiple myeloma. Lille Chirurgical 6(34): 183

Liebermann, T.; Sagi, T. 1959: Tumor of the outer ear obstructing the acoustic canal: otological case of benign cutaneous lymphadenosis. Borgyogyaszati Es Venerologiaia Szemle 35: 279-282

Aurousseau, L.; Chome, J.; Bergeron, R. 1957: Tumor of the ovarian theca cells. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 9(1): 18-24

Hartwig, W. 1960: Tumor of the pancreas complicated by diabetes with variable reaction to insulin. Polski Tygodnik Lekarski 15: 679-683

Arnesen, K. 1953: Tumor of the parotid gland in lymphatic leukemia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 73(22): 850-852

Tardieu, G.; Klein, M.R. 1957: Tumor of the peduncle successfully operated under controlled artificial respiration. Revue Neurologique (Paris) 97(2): 137-139

Mendenhall, E.N. 1950: Tumor of the pineal body with high insulin resistance. Journal of the Indiana State Medical Association 43(1): 32-36 Illust

Smirnova, G.G.; Odinokova, V.A. 1961: Tumor of the pineal gland. Problemy Endokrinologii i Gormonoterapii 7: 97-100

Khelimskii, A.M. 1962: Tumor of the pineal gland with endocrine disorders. Problemy Endokrinologii i Gormonoterapii 8: 108-112

Marconi, R. 1951: Tumor of the posterior mediastinum: myxosarcoma with elements of chondroma and chordoma. Minerva Chirurgica 6(16): 440-444

Coccolo, G.F. 1952: Tumor of the renal hilus. Il Friuli Medico 7(1): 27-33

Haba, T.; Furukawa, M.; Matsuda, I.; Hasegawa, S.; Arai, K.; Ishii, T. 1962: Tumor of the renal pelvis or ureter: report of 3 cases. Hinyokika Kiyo. Acta Urologica Japonica 8: 404-414

Firstater, M. 1955: Tumor of the renal pelvis; conservative surgery. Revista Argentina de Urologia 24(7-9): 371-379

Taiana, J.A.; Villega, A.H.; Pini, A.E.; Casal, J. 1955: Tumor of the retroperitoneum; thoracophrenolaparotomy; exeresis. Prensa Medica Argentina 42(49): 3693-3697

Cordeiro, A. 1962: Tumor of the right auricle. Jornal do Medico 47: 641-648

Jorge; Taiana, A.; Casal, J.; Buquet, J. 1953: Tumor of the right kidney; thoraco-abdominal nephrectomy. Revista Argentina de Urologia 22(7-8): 204-208

Morris, G.E.; Kroger, L. 1950: Tumor of the right shin in a 71 year old man (lymphosarcoma or reticulum cell sarcoma?). Archives of Dermatology and Syphilology 61(6): 1070

Dejean; Boudet; Paycha; Jaulmes 1954: Tumor of the rim of sclera due to soot cancer. Bulletin des Societes d'Ophtalmologie de France 6: 627-630

Otto, G. 1961: Tumor of the round ligament and the breast. Zentralblatt für Gynakologie 83: 923-925

Talić, A.; Gavrankapetanović, I.; Lazović, M.; Mahić, M.; Biscević, M. 2004: Tumor of the sacroiliac region. Medicinski Arhiv 58(1): 51-52

Dejean, C.; Boudet; Paycha; Jaulmes 1958: Tumor of the sclero-corneal junction in soot disease. Montpellier Medical 53(4): 726-728

Tzanck, A.; Melki, G.R.; Lefort 1951: Tumor of the scrotum; case for diagnosis. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 58(3): 225-227

Trabucco, A.; Cartelli, N.; Marquez, F.J. 1951: Tumor of the seminal vesicles; considerations on two cases. Revista Argentina de Urologia 20(9-11): 258-270

Lazorthes, G.; Anduze-Acher, H.; Espagno, J. 1959: Tumor of the septum lucidum (apropos of a case). Remarks on cysts and tumors of this region. Revue d'Oto-Neuro-Ophtalmologie 31: 339-341

Bonch-Osnolovskii, E.E.; Treister, T.N.; Tolstyi, N.I. 1958: Tumor of the shin resulting from marching. Voenno-Meditsinskii Zhurnal 5(1): 40-43

Bull, F.E.; Dodge, H.W.; Hanlon, D.G.; Sickert, R.C. 1956: Tumor of the spinal cord; occurrence in patients with pernicious anemia and subacute combined sclerosis. Journal of the American Medical Association 162(8): 707-709

Urso, L.; Rollo, G. 1957: Tumor of the stomach contemporaneous with invaginating tumor of the cecum. Annali Italiani di Chirurgia 34(6): 401-412

Mtskhvetadze, V.L. 1957: Tumor of the testicle; its treatment and clinical study. Voprosy Onkologii 3(3): 331-336

Perez Irezabal, J. 1952: Tumor of the testis with extensive lumbo-abdominal metastasis associated with tuberculous pyonephrosis of the same side. Archivos Espanoles de Urologia 8(2): 154-159

Chabrut, R.; Marcel, J.E. 1956: Tumor of the testis; pulmonary and orbital metastases; Sinus pericranii. Archives Francaises de Pediatrie 13(10): 1111-1117

Habib, E.; Dousset, B.; Sauvanet, A. 2006: Tumor of the third portion of the duodenum. Journal de Chirurgie 143(3): 180-184

Welch, K. 1954: Tumor of the third ventricle. Transactions of the American Neurological Association 13(79th Meeting): 232-233

Nielsen, J.M. 1959: Tumor of the third ventricle with amnesia following minor accident: report of two cases. Bulletin of the Los Angeles Neurological Society 24: 180-183

Palma, E.C.; Medoc, J. 1952: Tumor of the third ventricle; anatomico-clinical and surgical study. Anales de la Facultad de Medicina de Montevideo 37(5-6): 153-164

Roussel, A.; Barbe, A.; Longefait, M.; Tremoulet, A. 1961: Tumor of the thymic loge in a 6-year-old child. Pediatrie 16: 92-93

Kucherenko, A.E.; Kadoshchuk, T.A. 1961: Tumor of the thymus with an unusual localization in the neck. Voprosy Onkologii 7(11): 88-90

Bernard, J.; Najean, Y.; Slama, R. 1962: Tumor of the thymus with erythroblastopenia. Remarkable effectiveness of corticotherapy on the erythropoietic function. Nouvelle Revue Francaise d'Hematologie 2: 776-780

Bernard, J.; Slama, R.; Najean, Y. 1962: Tumor of the thymus with erythroblastopenia. The remarkable effectiveness of corticotherapy for bone marrow function. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 113: 600-606

Couespel, R.; Gaillard, J.A.; Vaillant, G. 1960: Tumor of the thymus, anemia and erythroblastic hypoplasia. Journal Francais de Medecine et Chirurgie Thoraciques 14: 617-630

Mahaux, J. 1954: Tumor of the thyroid; new therapeutic aspects. Bruxelles Medical 34(31): 1467-1482

Harmouch, A.; Sefiani, S.; Oujilal, A.; Elmjareb, C.; Kamouni, M.; Maher, M.; Saidi, A. 2006: Tumor of the tongue in a child. Annales de Pathologie 26(2): 139-141

Czarnecki, H. 1961: Tumor of the tongue in pregnancy. Otolaryngologia Polska 15: 383-386

Fernandez Marino, V.; Sanchez Rementeria, J. 1953: Tumor of the tongue: carcinoma. Boletin de la Liga Contra El Cancer. Liga Contra El Cancer 28(6): 146-147

Cowen, R. 1957: Tumor of the tunica vaginalis testis: case report of neurilemmoma. Journal of Urology 77(1): 59-61

Badri, T.; Fazaa, B.; Zermani, R.; Sfar, R.; Ben Jilani, S.; Kamoun, M.-R. 2005: Tumor of the umbilicus. Annales de Dermatologie et de Venereologie 132(1): 55-57

Van Tassel, W.R. 1950: Tumor of the urachus. Connecticut State Medical Journal 14(1): 27-29

Mendoza, S. 1962: Tumor of the urachus. Clinical case. Revista de Urologia 20: 151-156

Ohori, T.; Kon, S.; Koyano, M. 1962: Tumor of the ureter: report of a case with clinical findings suggesting calculus. Hinyokika Kiyo. Acta Urologica Japonica 8: 673-677

Gonzalez, R.; Firstater, M.; Gomez, J.M. 1951: Tumor of the ureter; total nephroureterectomy and partial cystectomy. Revista Argentina de Urologia 20(5-6): 125-130

Parnes, I.H. 1955: Tumor of the vagus nerve. Surgery 37(6): 955-958

Van Demark, R.E. 1955: Tumor of the wrist of anomalous muscle origin. Journal of Bone and Joint Surgery. American Volume 37-A(6): 1284-1285

Rabii, R.; el Mejjad, A.; Fekak, H.; Querfani, B.; Joual, A.; el Mrini, M. 2003: Tumor of upper urinary tract in renal polycystic disease. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(4): 686-689

Schneider, K. 1950: Tumor or incapsulated exudate in the posterior mediastinal pleural space. Fortschritte auf dem Gebiete der Rontgenstrahlen 72(6): 736-738

Magois, E.; Glérant, J.C.; Toublanc, B.; Mayeux, I.; Mispelaere, D.; Sevestre, H.; Jounieaux, V. 2005: Tumor or not tumor?: that's the question. Revue des Maladies Respiratoires 22(3): 487-489

Weylman, W.T.; Simon, H. 1961: Tumor or varices. JAMA 177: 202-203

Pezzolo, A.; Parodi, F.; Corrias, M.V.; Cinti, R.; Gambini, C.; Pistoia, V. 2007: Tumor origin of endothelial cells in human neuroblastoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(4): 376-383

Haas, L.L.; Baker, B. 1955: Tumor outline of esophageal carcinoma. Radiology 64(2): 241-248

Mason, R.P.; Hunjan, S.; Constantinescu, A.; Song, Y.; Zhao, D.; Hahn, E.W.; Antich, P.P.; Peschke, P. 2003: Tumor oximetry: comparison of 19F MR EPi and electrodes. Advances in Experimental Medicine and Biology 530: 19-27

Song, Y.; Worden, K.L.; Jiang, X.; Zhao, D.; Constantinescu, A.; Liu, H.; Mason, R.P. 2003: Tumor oxygen dynamics: comparison of 19F MR EPi and frequency domain NIR spectroscopy. Advances in Experimental Medicine and Biology 530: 225-236

Vaupel, P.; Höckel, M. 2003: Tumor oxygenation and its relevance to tumor physiology and treatment. Advances in Experimental Medicine and Biology 510: 45-49

O'Hara, J.A.; Blumenthal, R.D.; Grinberg, O.Y.; Grinberg, S.; Wilmot, C.; Goldenberg, D.M.; Swartz, H.M. 2003: Tumor pO2 assessments in human xenograft tumors measured by EPR oximetry: location of paramagnetic materials. Advances in Experimental Medicine and Biology 530: 205-214

Bertolotto, R. 1956: Tumor phyllodes of the mammary gland. Acta Chirurgica Italica 12(1): 111-129

Muller-Matheesen, W.G. 1954: Tumor problems. Hippokrates 25(3): 71-74

McCARTER, J.A. 1959: Tumor production in relation to benzpyrene in skin. Acta - Unio Internationalis Contra Cancrum 15(1): 178-180

Roepman, P.; Holstege, F.C.P. 2005: Tumor profiling turmoil. Cell Cycle 4(5): 659-660

De Clerck, Y.A.; Weissman, B.E.; Yu, D.; Parsons, R.; Bar-Eli, M.; Roy-Burman, P.; Seewaldt, V.L.; Cress, A.E.; Languino, L.R.; Batra, S.K.; Tang, C.K.; Sheng, S.; Chen, W-Tien.; Chellappan, S.; Cheng, S-Yuan.; Ladisch, S.; McCarthy, J.B.; Coussens, L.M.; Cohen, M.B. 2006: Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology and Therapy 5(12): 1588-1599

Koga, Y.; Kitajima, Y.; Miyoshi, A.; Sato, K.; Kitahara, K.; Soejima, H.; Miyazaki, K. 2005: Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Annals of Surgical Oncology 12(5): 354-363

Adam, Ré.; Pascal, G.; Castaing, D.; Azoulay, D.; Delvart, V.; Paule, B.; Levi, F.; Bismuth, H. 2004: Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Annals of Surgery 240(6): 1052-61; Discussion 1061-4

Pardee, A.B. 2006: Tumor progression--targets for differential therapy. Journal of Cellular Physiology 209(3): 589-591

Setala, H. 1956: Tumor promoting and cocarcinogenic effects of some non-ionic lipophilic-hydrophilic (surface active) agents; an experimental study on skin tumors in mice. Acta pathologica et microbiologica Scandinavica. Supplement 39(Suppl 115): 1-93

Marks, F.; Fürstenberger, G.; Müller-Decker, K. 2007: Tumor promotion as a target of cancer prevention. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 174: 37-47

Tiacci, E.; Orvietani, P-Luigi.; Bigerna, B.; Pucciarini, A.; Corthals, G.L.; Pettirossi, V.; Martelli, M.P.; Liso, A.; Benedetti, R.; Pacini, R.; Bolli, Nò.; Pileri, S.; Pulford, K.; Gambacorta, M.; Carbone, A.; Pasquarello, C.; Scherl, A.; Robertson, H.; Sciurpi, M.Teresa.; Alunni-Bistocchi, G.; Binaglia, L.; Byrne, J.A.; Falini, B. 2005: Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. Blood 105(7): 2812-2820

Jiang, P.-H.; Motoo, Y.; Iovanna, J.L.; Pébusque, M.-J.èp.; Xie, M.-J.; Okada, G.; Sawabu, N. 2004: Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas. Jop: Journal of the Pancreas 5(4): 205-216

Crokart, N.; Radermacher, K.; Jordan, B.én.éd.F.; Baudelet, C.; Cron, G.O.; Grégoire, V.; Beghein, N.; Bouzin, C.; Feron, O.; Gallez, B. 2005: Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Research 65(17): 7911-7916

Ströbel, P.; Bauer, A.; Puppe, B.; Kraushaar, T.; Krein, A.; Toyka, K.; Gold, R.; Semik, M.; Kiefer, R.; Nix, W.; Schalke, B.; Müller-Hermelink, H.Konrad.; Marx, A. 2004: Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(8): 1501-1509

Hayes-Jordan, A.A.; Daw, N.C.; Furman, W.L.; Hoffer, F.A.; Shochat, S.J. 2004: Tumor recurrence at thoracostomy tube insertion sites: a report of two pediatric cases. Journal of Pediatric Surgery 39(10): 1565-1567

Akkad, T.; Gozzi, C.; Deibl, M.; Müller, T.; Pelzer, A.E.; Pinggera, G.M.; Bartsch, G.; Steiner, H. 2006: Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. Journal of Urology 175(4): 1268-1271; Discussion 1271

Pascual Regueiro, D.; García de Jalón Martínez, A.; Sancho Serrano, C.; Mallén Mateo, E.; Blas Marín, M.; Rioja Sanz, L.A. 2003: Tumor recurrence in the resected area of the ureteral meatus after endoscopic disinsertion during radical nephroureterectomy. Actas Urologicas Espanolas 27(4): 308-311

Camacho Martí, V.; Estorch Cabrera, M.; Mena González, E.; Fuertes Manuel, J.; Hernández Fructuoso, M.A.; Flotats Giralt, A.; Carrió Gasset, I. 2004: Tumor redifferentiation in papillary thyroid carcinoma alter retinoic acid administration. Revista Espanola de Medicina Nuclear 23(3): 193-196

Weber, J.S. 2005: Tumor regression and autoimmunity in cytotoxic T lymphocyte-associated antigen 4 blockade-treated patients. Annals of Surgical Oncology 12(12): 957-959

Maker, A.V.; Phan, G.Q.; Attia, P.; Yang, J.C.; Sherry, R.M.; Topalian, S.L.; Kammula, U.S.; Royal, R.E.; Haworth, L.R.; Levy, C.; Kleiner, D.; Mavroukakis, S.A.; Yellin, M.; Rosenberg, S.A. 2005: Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/Ii study. Annals of Surgical Oncology 12(12): 1005-1016

Welniak, L.A.; Shorts, L.; Subleski, J.; Blazar, B.R.; Wiltrout, R.H.; Murphy, W.J. 2004: Tumor regression by anti-CD40 and interleukin-2: role of CD40 in hematopoietic cells and organ-specific effects. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 10(8): 534-539

Hsieh, Y.-H.; Liu, H.-P.; Lo, S.J.; Chang, Y.-s. 2006: Tumor regression by expression of high physiological levels of EBV latent membrane protein 1. Cancer Biology and Therapy 5(3): 310-317

Datta, N.R.; Rajkumar, A.; Basu, R. 2004: Tumor regression dynamics with external radiotherapy in cancer cervix and its implications. Indian Journal of Cancer 41(1): 18-24

Pohlen, U.; Berger, G.; Jung, M.; Rezska, R.; Regenstein, J.; Buhr, H.J. 1998: Tumor regression in long-term follow-up by administration of liposome encapsulated 5-FU. An animal experiment in WAF rats with CC-531 liver tumor. Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 625-629

Caricato, M.; Ausania, F.; De Dominicis, E.; Vincenzi, B.; Rabitti, C.; Tonini, G.; Cellini, F.; Coppola, R. 2007: Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33(6): 724-728

Tahara-Hanaoka, S.; Shibuya, K.; Kai, H.; Miyamoto, A.; Morikawa, Y.; Ohkochi, N.; Honda, S.-i.; Shibuya, A. 2006: Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 107(4): 1491-1496

Cheng, C.; Zhou, Z.-X.; Xu, M.; Zhao, W.; Xu, J.; Zeng, L.; Huang, Y.; Wu, Q.-H.; Dai, J.-F.; Ying, K.; Xie, Y.; Mao, Y.-M. 2002: Tumor relevance analysis of a highly conserved gene by using gene microarray hybridization. Yi Chuan 24(3): 227-231

Loefer, J.B.; Mefferd, R.B. 1952: Tumor resistance phenomena. IV. Acquired resistance. Texas Reports on Biology and Medicine 10(4): 849-854

Ishimori, T.; Tatsumi, M.; Wahl, R.L. 2005: Tumor response assessment is more robust with sequential CT scanning than external caliper measurements. Academic Radiology 12(6): 776-781

Madelaine, J.; Cadranel, J.; Zalcman, G. 2004: Tumor response to gefitinib (IRESSA) in pulmonary adenocarcinoma: toward a molecular basis for therapeutic targetting. Revue des Maladies Respiratoires 21(5 Part 1): 881-885

Donington, J.S.; Miller, D.L.; Allen, M.S.; Deschamps, C.; Nichols, F.C.; Pairolero, P.C. 2003: Tumor response to induction chemoradiation: influence on survival after esophagectomy. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 24(4): 631-636; Discussion: 636-637

Wachsberger, P.; Burd, R.; Dicker, A.P. 2003: Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(6): 1957-1971

Selawry, O.S.; Carlson, J.C.; Moore, G.E. 1958: Tumor response to ionizing rays at elevated temperatures: a review and discussion. American Journal of Roentgenology Radium Therapy and Nuclear Medicine 80(5): 833-839

Kelley, S.T.; Coppola, D.; Yeatman, T.; Marcet, J. 2005: Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways. Clinical Colorectal Cancer 5(2): 114-118

Kenny, P.A.; Bissell, M.J. 2003: Tumor reversion: correction of malignant behavior by microenvironmental cues. International Journal of Cancer 107(5): 688-695

Cho-Chung, Y.S.; Nesterova, M.V. 2005: Tumor reversion: protein kinase a isozyme switching. Annals of the new York Academy of Sciences 1058: 76-86

Geller, J.I.; Santana, V.M. 2004: Tumor rupture and mitotic index in pediatric sex cord-stromal tumors. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 22(10): 2032-3; author reply 2033-5

Decker, G.A.; Gores, G.J.; Roberts, L.R. 2003: Tumor seeding complicating radiofrequency ablation of hepatocellular carcinoma. Journal of Hepatology 38(5): 692

Yamakado, K.; Akeboshi, M.; Nakatsuka, A.; Takaki, H.; Takao, M.; Kobayashi, H.; Taguchi, O.; Takeda, K. 2005: Tumor seeding following lung radiofrequency ablation: a case report. Cardiovascular and Interventional Radiology 28(4): 530-532

Treuthardt, C.; Danuser, H.; Studer, U.E. 2004: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis. European Urology 46(4): 442-443

Warren, S. 1949: Tumor seminar; neoplasms of the lymphatic system. Texas State Journal of Medicine 45(12): 816

Fedorov, V.I. 1962: Tumor sensitivity and operability of stomach cancers. Zdravookhranenie Belorussii 8: 10-13

Curlee, K.V.; Parker, W.B.; Sorscher, E.J. 2004: Tumor sensitization to purine analogs by E. coli PNP. Methods in Molecular Medicine 90: 223-245

Hiltemann, H. 1955: Tumor sequestration in the breast. Fortschritte auf dem Gebiete der Rontgenstrahlen 83(4): 593-594

Basabe, H.; Gentile, F.A.; Marcucci Poltri, J. 1956: Tumor shadows in tuberculosis. La Semana Medica 108(13): 418

Schulz, A.; Zehrer, G. 1953: Tumor shaped endometriosis in the thigh. Zentralblatt für Chirurgie 78(17): 708-710

Sandor, I. 1952: Tumor simulating endocarditis lenta; kidney sarcoma with cardiac metastasis. Orvosi Hetilap 93(14): 426-427

Stephanopoulos, K. 1951: Tumor simulating tracheobronchial glandular tuberculosis, as a manifestation of primary infections in the adult. Therapeutische Umschau und Medizinische Bibliographie. Revue Therapeutique et Bibliographie Medicale 8(5): 64-70

Grabenbauer, G.G.; Kessler, H.; Matzel, K.E.; Sauer, R.; Hohenberger, W.; Schneider, I.H.F. 2005: Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Diseases of the Colon and Rectum 48(9): 1742-1751

Duffy, S.W.; Tabar, L.; Vitak, B.; Warwick, J. 2006: Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?. Breast Journal 12(Suppl 1): S91-S95

Tresserra, F.; Rodriguez, I.; García-Yuste, M.; Grases, P.J.; Ara, C.; Fabregas, R. 2007: Tumor size and lymph node status in multifocal breast cancer. Breast Journal 13(1): 68-71

Chik, B.H.; Liu, C.Leung.; Fan, S.Tat.; Lo, C.Mau.; Poon, R.T.P.; Lam, C.Ming.; Wong, J. 2007: Tumor size and operative risks of extended right-sided hepatic resection for hepatocellular carcinoma: implication for preoperative portal vein embolization. Archives of Surgery 142(1): 63-9; Discussion 69

Maffuz, A.; Barroso-Bravo, S.; Nájera, I.; Zarco, G.; Alvarado-Cabrero, I.; Rodríguez-Cuevas, S.A. 2006: Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. Journal of Experimental and Clinical Cancer Research: Cr 25(2): 223-227

Pawlik, T.M.; Delman, K.A.; Vauthey, J-Nicolas.; Nagorney, D.M.; Ng, I.Oi-Lin.; Ikai, I.; Yamaoka, Y.; Belghiti, J.; Lauwers, G.Y.; Poon, R.T.; Abdalla, E.K. 2005: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 11(9): 1086-1092

Anonymous 2004: Tumor size versus biology in screen lung cancer with CT. Cancer Biology and Therapy 3(5): 429

Gray, S.W.; Skandalakis, J.W.; Mitchell, W.E.; Nicolson, W.P.; McRAE, F.W. 1961: Tumor size, duration of symptoms, and prognosis in carcinoma of the breast. Surgery 49: 143-148

Warnke, P.H.; Terheyden, H.; Açil, Y.; Springer, I.N.; Sherry, E.; Reynolds, M.; Russo, P.A.J.; Bredee, J.P.; Podschun, R. 2004: Tumor smell reduction with antibacterial essential oils. Cancer 100(4): 879-880

Uenaka, A.; Nakayama, E. 2005: Tumor specific antigen and cytotoxic T lymphocytes. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 568-573

Ichiki, Y.; Hanagiri, T.; Takenoyama, M.; Baba, T.; Fukuyama, T.; Nagata, Y.; Mizukami, M.; So, T.; Sugaya, M.; Yasuda, M.; So, T.; Sugio, K.; Yasumoto, K. 2005: Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy. Lung Cancer 48(2): 281-289

Juergens, K.U.; Weckesser, M.; Stegger, L.; Franzius, C.; Beetz, M.; Schober, O.; Heindel, W.; Wormanns, D. 2006: Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?. European Radiology 16(5): 1131-1137

Kopper, L.ás.ó; Hajdú, M. 2006: Tumor stem cells--a possible scenario. Magyar Onkologia 50(2): 101-106

Keller, H.L.; Schober, R. 1956: Tumor structure and distribution of ionization in tissue. Strahlentherapie 101(3): 371-375

Sugimoto, M.; Takahashi, A.; Hara, E. 2006: Tumor suppression by cellular senescence: molecular link between aging and cancer. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 51(1): 10-17

Folkman, J. 2006: Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Science's Stke: Signal Transduction Knowledge Environment 354: Pe35

Bao, W.; Zhang, L.-h.; Jia, L.-t.; Qu, P.; Wang, C.-j.; Yang, A.-g. 2004: Tumor suppression of a constitutively active caspase-3 in the SKBr-3 breast carcinoma xenograft mice model. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 20(1): 23-26

Arsham, A.M.; Simon, M.C. 2003: Tumor suppression through angiogenesis inhibition. Methods in Molecular Biology 223: 249-270

Takai, S.; Miyazaki, M. 2006: Tumor suppressive effect. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 512-517

Ridnour, L.A.; Oberley, T.D.; Oberley, L.W. 2004: Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxidants and Redox Signaling 6(3): 501-512

Sandee, D.; Tungpradabkul, S.; Laohathai, K.; Punyammalee, B.; Kohda, K.; Takagi, M.; Imanaka, T. 2002: Tumor suppressive monoclonal antibody belonging to the V(H) 7183 family directed to the oncodevelopmental carbohydrate antigen on human hepatocellular carcinoma. Journal of Bioscience and Bioengineering 93(3): 266-273

Narayan, S.; Jaiswal, A.S.; Balusu, R. 2005: Tumor suppressor APC blocks DNA polymerase beta-dependent strand displacement synthesis during long patch but not short patch base excision repair and increases sensitivity to methylmethane sulfonate. Journal of Biological Chemistry 280(8): 6942-6949

Ghosh, S.; Lu, Y.; Katz, A.; Hu, Y.; Li, R. 2007: Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. American Journal of Physiology. Endocrinology and Metabolism 292(1): E246-E252

Chen, J.; Chada, S.; Mhashilkar, A.; Miano, J.M. 2003: Tumor suppressor MDA-7/IL-24 selectively inhibits vascular smooth muscle cell growth and migration. Molecular Therapy: the Journal of the American Society of Gene Therapy 8(2): 220-229

Zhang, X.; Zhang, Y.-w.; Liu, S.; Bulloj, A.; Tong, G.G.; Zhang, Z.; Liao, F.-F.; Xu, H. 2006: Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau. Molecular Neurodegeneration 1: 7

Fuchs, S.Y. 2005: Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor. Cancer Biology and Therapy 4(5): 506-508

Heikkilä, A.; Tuomisto, T.; Häkkinen, S.-K.; Keski-Nisula, L.; Heinonen, S.; Ylä-Herttuala, S. 2005: Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia--an array study on case-specific human preeclamptic placental tissue. Acta Obstetricia et Gynecologica Scandinavica 84(7): 679-689

Zhao, Y.L.; Piao, C.Q.; Hei, T.K. 2003: Tumor suppressor function of Betaig-h3 gene in radiation carcinogenesis. Advances in Space Research: the Official Journal of the Committee on Space Research 31(6): 1575-1582

Middendorp, S.; Zijlstra, A.J.E.; Kersseboom, R.; Dingjan, G.M.; Jumaa, H.; Hendriks, R.W. 2005: Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood 105(1): 259-265

Pećina-Slaus, N. 2003: Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell International 3(1): 17

Sato, W.; Horie, Y.; Watanabe, S.; Suzuki, A. 2005: Tumor suppressor gene PTEN and non-alcoholic steatohepatitis (NASH). Nihon Rinsho. Japanese Journal of Clinical Medicine 63(8): 1475-1483

Zhang, Y.-t.; Chen, N.; Zeng, H.; Zhou, Q. 2006: Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma. Zhonghua Bing Li Xue Za Zhi 35(9): 562-564

Tug, E.; Tug, T.; Elyas, H.; Coskunsel, M.; Emri, S. 2006: Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey. Journal of Carcinogenesis 5: 23

Ozolek, J.A.; Hunt, J.L. 2006: Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. American Journal of Surgical Pathology 30(12): 1576-1580

Nagashima, T. 2005: Tumor suppressor gene in brain tumors. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 44-48

Takimoto, R.; Niitsu, Y. 2004: Tumor suppressor gene p53 and molecular targeting therapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1309-1313

Dulaimi, E.; Hillinck, J.; Ibanez de Caceres, I.; Al-Saleem, T.; Cairns, P. 2004: Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(18 Part 1): 6189-6193

Roth, J.A.; Grammer, S.F. 2003: Tumor suppressor gene therapy. Methods in Molecular Biology 223: 577-598

Meng, R.D.; El-Deiry, W.S. 1998: Tumor suppressor gene therapy for cancer: from the bench to the clinic. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer ChemoTherapy 1(3): 205-210

Dohn, M.; Nozell, S.; Willis, A.; Chen, X. 2003: Tumor suppressor gene-inducible cell lines. Methods in Molecular Biology 223: 221-235

Testa, J.R.; Hino, O.; Knudson, A.G. 2003: Tumor suppressor genes and the two-hit model of recessive oncogenesis: celebrating Alfred Knudson's 80th birthday. Genes Chromosomes and Cancer 38(4): 286-287

Oliveira, A.M.; Ross, J.S.; Fletcher, J.A. 2005: Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. American Journal of Clinical Pathology 124 Suppl: S16-S28

Virmani, A.K.; Gazdar, A.F. 2003: Tumor suppressor genes in lung cancer. Methods in Molecular Biology 222: 97-115

Tanaka, M.; Grossman, H.B. 2003: Tumor suppressor genes of bladder cancer and potential for gene therapy. Advances in Experimental Medicine and Biology 539(Part A): 185-191

Sussan, T.E.; Pletcher, M.T.; Murakami, Y.; Reeves, R.H. 2005: Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression. Molecular Cancer 4: 28

Knowles, M.A. 2007: Tumor suppressor loci in bladder cancer. Frontiers in Bioscience: a Journal and Virtual Library 12: 2233-2251

Carroll, S.L.; Stonecypher, M.S. 2005: Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. the role of dysregulated growth factor signaling. Journal of Neuropathology and Experimental Neurology 64(1): 1-9

Gonzalez-Paz, N.; Chng, W.J.; McClure, R.F.; Blood, E.; Oken, M.M.; Van Ness, B.; James, C.D.; Kurtin, P.J.; Henderson, K.; Ahmann, G.J.; Gertz, M.; Lacy, M.; Dispenzieri, A.; Greipp, P.R.; Fonseca, R. 2007: Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications. Blood 109(3): 1228-1232

El-Sayed, Z.A.; Farag, D.H.; Eissa, S. 2003: Tumor suppressor protein p53 and anti-p53 autoantibodies in pediatric rheumatological diseases. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 14(3): 229-233

Giles, R.H.; Voest, E.E. 2005: Tumor suppressors APC and VHL: gatekeepers of the intestine and kidney. Progress in Molecular and Subcellular Biology 40: 151-181

Buendia, M.A. 2007: Tumor suppressors in hepatocellular carcinoma: many are called, but few are chosen. Journal of Hepatology 46(4): 546-548

Giebel, B.; Wodarz, A. 2006: Tumor suppressors: control of signaling by endocytosis. Current Biology: Cb 16(3): R91-R92

Hamberger, C.A. 1963: Tumor surgery in otorhinolaryngology. Nordisk Medicin 69: 157-160

Roberts, J.P. 2005: Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005(11 Suppl 2: S45-S46

Bach, W. 1961: Tumor susceptibility and leukosis (simultaneous appearance of vulva carcinoma, skin sarcoma, skin carcinoma, and lymphatic leukemia). Zentralblatt für Gynakologie 83: 1684-1689

Potvliege, P. 1952: Tumor syndrome of the base of the cranium; anatomo-clinical study. Acta Neurologica et Psychiatrica Belgica 52(6): 365-370

Ghosh, A.; Heston, W.D.W. 2004: Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. Journal of Cellular Biochemistry 91(3): 528-539

Toublan, F.J.-J.; Boppart, S.; Suslick, K.S. 2006: Tumor targeting by surface-modified protein microspheres. Journal of the American Chemical Society 128(11): 3472-3473

Wang, X.-l.; Wang, F.; Wu, J.-h.; Yi, M.-y.; Xu, P.; Zhao, X.-f.; Xue, Y.-h.; Huang, Q. 2005: Tumor targeting gene transfer mediated by electroporation for growth suppression of retinoblastoma in vivo. Chinese Journal of Ophthalmology 41(10): 900-904

Khawli, L.A.; Alauddin, M.M.; Hu, P.; Epstein, A.L. 2003: Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody. Cancer BioTherapy and Radiopharmaceuticals 18(6): 931-940

Berman, J.J. 2004: Tumor taxonomy for the developmental lineage classification of neoplasms. Bmc Cancer 4: 88

Vrbanic, D.; Jaksic, N. 1960: Tumor thecacellularis. Medicinski Glasnik 14: 253-257

Bullitt, E.; Lin, N.U.; Ewend, M.G.; Zeng, D.; Winer, E.P.; Carey, L.A.; Smith, J.Keith. 2006: Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer. Medical Image Computing and Computer-Assisted Intervention: Miccai .. International Conference on Medical Image Computing and Computer-Assisted Intervention 9(Pt 2): 561-568

Wajant, H.; Gerspach, J.; Pfizenmaier, K. 2005: Tumor therapeutics by design: targeting and activation of death receptors. Cytokine and Growth Factor Reviews 16(1): 55-76

Harbort, G.; Schaefers, E. 1959: Tumor therapy according to Leupold. Archiv für Gynakologie 193: 214-217

O'Brien, C.J.; Lauer, C.S.; Fredricks, S.; Clifford, A.R.; McNeil, E.B.; Bagia, J.S.; Koulmandas, C. 2003: Tumor thickness influences prognosis of T1 and T2 oral cavity cancer--but what thickness?. Head and Neck 25(11): 937-945

Jibiki, M.; Inoue, Y.; Sugano, N.; Iwai, T.; Katou, T. 2006: Tumor thrombectomy without bypass for low-grade malignant tumors extending into the inferior vena cava: report of two cases. Surgery Today 36(5): 465-469

Brecher, C.W.; Lang, E.V. 2004: Tumor thromboembolism masquerading as bland pulmonary embolism. Journal of Vascular and Interventional Radiology: Jvir 15(3): 293-296

Felder, D.A. 1960: Tumor thrombosis of the abdominal aorta and iliac arteries. Report of a case. Minnesota Medicine 43: 392-395

Brili, S.; Barberis, V.I.; Drollias, A.; Barbetseas, J.; Stefanadis, C. 2005: Tumor thrombus extending from the inferior vena cava into the right atrium: first manifestation of renal neoplasia in a patient with mitral stenosis. Echocardiography 22(8): 693-694

Yamaguchi, M.; Midorikawa, T.; Saitoh, M.; Kadokura, S.; Miyagawa, K.; Sanada, Y.; Kumada, K. 2003: Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein. Hepato-Gastroenterology 50(53): 1693-1696

Dotor, E.; Cuatrecases, M.; Martínez-Iniesta, M.ía.; Navarro, M.; Vilardell, F.; Guinó, E.; Pareja, L.; Figueras, A.és.; Molleví, D.G.; Serrano, T.; de Oca, J.; Peinado, M.A.; Moreno, V.íc.; Germà, J.R.ón.; Capellá, G.; Villanueva, A. 2006: Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(10): 1603-1611

Bersteĭn, L.M.; Chernobrovkina, A.E.; Gamaiunova, V.B.; Vasil'ev, D.A.; Kovalevskiĭ, A.I.; Maksimov, S.I.; Chepik, O.F.; Gershfel'd, E.D. 2003: Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer. Voprosy Onkologii 49(1): 55-59

Schrohl, A.-S.; Holten-Andersen, M.N.; Peters, H.A.; Look, M.P.; Meijer-van Gelder, M.E.; Klijn, J.G.M.; Brünner, N.; Foekens, J.A. 2004: Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(7): 2289-2298

Petraki, C.; Vaslamatzis, M.; Argyrakos, T.; Petraki, K.; Strataki, M.; Alexopoulos, C.; Sotsiou, F. 2003: Tumor to tumor metastasis: report of two cases and review of the literature. International Journal of Surgical Pathology 11(2): 127-135

Petty, R.D.; Kerr, K.M.; Murray, G.I.; Nicolson, M.C.; Rooney, P.H.; Bissett, D.; Collie-Duguid, E.S.R. 2006: Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(11): 1729-1744

Fels, E. 1955: Tumor transformations of ovarian grafts into the kidney of female castrate rats. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149: 1666-1667

Schmidt, F. 1957: Tumor transmission by enema. Archiv für Geschwulstforschung 10(3-4): 293-302

Karnofsky, D.A.; Ridgway, L.P.; Patterson, P.A. 1952: Tumor transplantation to the chick embryo. Annals of the new York Academy of Sciences 55(2): 313-329

Zhang, B.; Chen, J.-Y.; Chen, D.-D.; Wang, G.-B.; Shen, P. 2004: Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World Journal of Gastroenterology 10(11): 1643-1646

Buraczewski, J. 1957: Tumor types of osseous actinomycosis of mandible in children. Pediatria Polska 32(2): 151-157

Peng, B.-G.; Liang, L.-J.; He, Q.; Kuang, M.; Lia, J.-M.; Lu, M.-D.; Huang, J.-F. 2005: Tumor vaccine against recurrence of hepatocellular carcinoma. World Journal of Gastroenterology 11(5): 700-704

Vieweg, J.; Dannull, J. 2003: Tumor vaccines: from gene therapy to dendritic cells--the emerging frontier. Urologic Clinics of North America 30(3): 633

Robinson, S.P.; Rijken, P.F.J.W.; Howe, F.A.; McSheehy, P.M.J.; van der Sanden, B.P.J.; Heerschap, A.; Stubbs, M.; van der Kogel, A.J.; Griffiths, J.R. 2003: Tumor vascular architecture and function evaluated by non-invasive susceptibility MRi methods and immunohistochemistry. Journal of Magnetic Resonance Imaging: Jmri 17(4): 445-454

Chen, B.; Pogue, B.W.; Luna, J.M.; Hardman, R.L.; Hoopes, P.J.; Hasan, T. 2006: Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(3 Part 1): 917-923

Buckanovich, R.J.; Sasaroli, D.; O'Brien-Jenkins, A.; Botbyl, J.; Hammond, R.; Katsaros, D.; Sandaltzopoulos, R.; Liotta, L.A.; Gimotty, P.A.; Coukos, G. 2007: Tumor vascular proteins as biomarkers in ovarian cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(7): 852-861

Seshadri, M.; Spernyak, J.A.; Mazurchuk, R.; Camacho, S.H.; Oseroff, A.R.; Cheney, R.T.; Bellnier, D.A. 2005: Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(11): 4241-4250

Corti, A.; Ponzoni, M. 2004: Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Annals of the new York Academy of Sciences 1028: 104-112

Hagen, T.L.M.t.; Eggermont, A.M.M. 2004: Tumor vascular therapy with TNF: critical review on animal models. Methods in Molecular Medicine 98: 227-246

Sarr, M.G.; Warshaw, A.L. 2005: Tumor versus neoplasm: Isn't it time to use the correct term--neoplasm?. Surgery 137(3): 297

Ishiwata, K.; Liu, H.-y.; Teramoto, K.; Kawamura, K.; Oda, K.; Arii, S. 2006: Tumor viability evaluation by positron emission tomography with [18F]FDG in the liver metastasis rat model. Annals of Nuclear Medicine 20(7): 463-469

Asai, K.; Sumiyama, Y.; Watanabe, M.; Aizawa, K. 2006: Tumor viability using real-time spectral images. Surgery Today 36(12): 1075-1084

Smadel, J.E. 1960: Tumor virus research program. National Cancer Institute Monograph 4: 1-5

Keberle, M.; Hoppe, F.; Dotzel, S.; Hahn, D. 2004: Tumor volume as determined by computed tomography predicts local control in hypopharyngeal squamous cell carcinoma treated with primary surgery. European Radiology 14(2): 286-291

Radovanović, D.; Mitrović, N.; Stevanović, D.; Pavlović, I.; Vuković, M.; Radojević, D. 2005: Tumor volume in advanced gastric cancer as a prognostic factor correlating with lymph node involvement. Medicinski Pregled 58(7-8): 351-356

Simon, J. 1958: Tumor with hydro-aeric picture: infected dermoid carcinoma. Bruxelles Medical 38(42): 1716-1724

Kojima, M. 1963: Tumor-Forming Leukemia (Including Chloroma). Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 26: 62-68

Cerecedo, L.R.; Smith, M.J.; Vicente, J. 1964: Tumor-Host Relationships Studied in Vitro: Experiments with Tissue Slices. Archives of Biochemistry and Biophysics 108: 7-11

Mayevsky, M.M.; Kutchkarev, R.N.; Romanenko, E.A.; Urasova, A.P.; Molkov, Y.N.; Timofeyevskaya, E.A.; Bondareva, A.S.; Masayeva, V.G.; Talysina, V.A.; Vyasova, O.I. 1964: Tumor-Inhibiting Action of Olivomycin (16749) and Antibiotic 2703 (Chrysomallin). (Experimental and Clinical Observations). Acta - Unio Internationalis Contra Cancrum 20: 286-288

Devenyi, I. 1964: Tumor-Like Drug-Induced Lymphadenopathy. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 105: 535-537

Samsonov, V.A.; Drobner, V.L. 1965: Tumor-Like Endometriosis of the Urinary Bladder with Compression of the Prevesicular Portion of the Ureter. Arkhiv Patologii 27: 77-79

Witwicki, T.; Tylman, D. 1964: Tumor-Like Osteitis. Chirurgia Narzadow Ruchu i Ortopedia Polska 29: 503-508

Condorelli, B.; Cali, G. 1963: Tumor-Like Tuberculosis of the Rhinopharynx. La Clinica Otorinolaringoiatrica 15: 64-71

Denny, W.A. 2004: Tumor-activated prodrugs--a new approach to cancer therapy. Cancer Investigation 22(4): 604-619

Müthing, J.; Meisen, I.; Kniep, B.; Haier, Jörg.; Senninger, N.; Neumann, U.; Langer, M.; Witthohn, K.; Milosević, J.; Peter-Katalinić, J. 2005: Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(1): 103-105

Krajewska, M.; Kim, H.; Shin, E.; Kennedy, S.; Duffy, M.J.; Wong, Y.F.; Marr, D.; Mikolajczyk, J.; Shabaik, A.; Meinhold-Heerlein, I.; Huang, X.; Banares, S.; Hedayat, H.; Reed, J.C.; Krajewski, S. 2005: Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(15): 5462-5471

Akhmedova, S.A.; Sergeeva, N.S.; Marshutina, N.V.; Mishunina, M.P.; Novikova, E.G. 2003: Tumor-associated antigen CA-125 in patients with ovarian cancer receiving various combinations of therapy. Voprosy Onkologii 49(1): 95-98

Kao, Y.-R.; Shih, J.-Y.; Wen, W.-C.; Ko, Y.-P.; Chen, B.-M.; Chan, Y.-L.; Chu, Y.-W.; Yang, P.-C.; Wu, C.-W.; Roffler, S.R. 2003: Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(7): 2807-2816

Oshikiri, T.; Miyamoto, M.; Morita, T.; Fujita, M.; Miyasaka, Y.; Senmaru, N.; Yamada, H.; Takahashi, T.; Horita, S.; Kondo, S. 2006: Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(2): 411-416

Heubeck, B.; Wendler, O.; Bumm, K.; Schäfer, R.; Müller-Vogt, U.; Häusler, M.; Meese, E.; Iro, H.; Steinhart, H. 2013: Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck--analysed by SEREX. European Journal of Cancer 49(4): e1-e7

Lewis, J.D.; Reilly, B.D.; Bright, R.K. 2003: Tumor-associated antigens: from discovery to immunity. International Reviews of Immunology 22(2): 81-112

Hakomori, S. 2001: Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Advances in Experimental Medicine and Biology 491: 369-402

Pastorekova, S.; Parkkila, S.; Zavada, J. 2006: Tumor-associated carbonic anhydrases and their clinical significance. Advances in Clinical Chemistry 42: 167-216

Heslin, M.J.; Hawkins, A.; Boedefeld, W.; Arnoletti, J.P.; Frolov, A.; Soong, R.; Urist, M.M.; Bland, K.I. 2005: Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Annals of Surgery 241(6): 941

Grover, A.C.; Tangrea, M.A.; Woodson, K.G.; Wallis, B.S.; Hanson, J.C.; Chuaqui, R.F.; Gillespie, J.W.; Erickson, H.S.; Bonner, R.F.; Pohida, T.J.; Emmert-Buck, M.R.; Libutti, S.K. 2006: Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. Journal of Translational Medicine 4: 13

Mikolajczyk, S.D.; Rittenhouse, H.G. 2004: Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease. Rinsho Byori. Japanese Journal of Clinical Pathology 52(3): 223-230

Ivanov, V.A.; Martinson, T.G.; Tiuriaeva, I.I. 2003: Tumor-associated hetero-organic antigens as markers of deranged cell differentiation and malignancy. Voprosy Onkologii 49(4): 467-471

Mantovani, A.; Schioppa, T.; Biswas, S.K.; Marchesi, F.; Allavena, P.; Sica, A. 2003: Tumor-associated macrophages and dendritic cells as prototypic type Ii polarized myeloid populations. Tumori 89(5): 459-468

Chen, J.J.W.; Lin, Y.-C.; Yao, P.-L.; Yuan, A.; Chen, H.-Y.; Shun, C.-T.; Tsai, M.-F.; Chen, C.-H.; Yang, P.-C. 2005: Tumor-associated macrophages: the double-edged sword in cancer progression. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(5): 953-964

Mengele, K.; Harbeck, N.; Reuning, U.; Magdolen, V.; Schmitt, M. 2005: Tumor-associated prognostic factors of the plasminogen activator family: determination and clinical value of u-PA, t-PA, PAI-1, and PAI-2. Hamostaseologie 25(3): 301-310

Eroles Vega, G.; Rondón Fernández, P.; Ferreiro López, D.; Romero Pérez, C.; Salcedo Pérez, S.; Lacambra Calvet, C.; Solis Villa, J. 2004: Tumor-associated significant pericardiac effusions: analysis of 18 cases. Revista Clinica Espanola 204(5): 260-263

Wolf, W.; Presant, C.A. 2004: Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics. Clinical Pharmacology and Therapeutics 76(5): 508; Author Reply 508-9

Schubert, R.; Renschler, H.; Schaub, R. 1960: Tumor-caused decay in bronchial carcinoma. Münchener Medizinische Wochenschrift 102: 173-178

Solá, Jé.Vicente.Ovejero.; Almonacid, G.Vides. 2006: Tumor-causing plant bacteria may infect animals. Medical Hypotheses 66(5): 1038-1039

Belkin, M.; Fitzgerald, D.B. 1952: Tumor-damaging capacity of plant materials. I. Plants used as cathartics. Journal of the National Cancer Institute 13(1): 139-155

Lee, W.T.; Shimizu, K.; Kuriyama, H.; Tanaka, H.; Kjaergaard, J.; Shu, S. 2005: Tumor-dendritic cell fusion as a basis for cancer immunotherapy. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 132(5): 755-764

Larmonier, N.; Marron, M.; Zeng, Y.; Cantrell, J.; Romanoski, A.; Sepassi, M.; Thompson, S.; Chen, X.; Andreansky, S.; Katsanis, E. 2007: Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunology Immunotherapy: Cii 56(1): 48-59

Ito, M.; Minamiya, Y.; Kawai, H.; Saito, S.; Saito, H.; Nakagawa, T.; Imai, K.; Hirokawa, M.; Ogawa, J.-i. 2006: Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. Journal of Immunology 176(9): 5637-5643

Bendre, M.S.; Margulies, A.G.; Walser, B.; Akel, N.S.; Bhattacharrya, S.; Skinner, R.A.; Swain, F.; Ramani, V.; Mohammad, K.S.; Wessner, L.L.; Martinez, A.; Guise, T.A.; Chirgwin, J.M.; Gaddy, D.; Suva, L.J. 2005: Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Research 65(23): 11001-11009

Scian, M.J.; Stagliano, K.E.R.; Anderson, M.A.E.; Hassan, S.; Bowman, M.; Miles, M.F.; Deb, S.P.; Deb, S. 2005: Tumor-derived p53 mutants induce NF-kappaB2 gene expression. Molecular and Cellular Biology 25(22): 10097-10110

Hassan, R.; Williams-Gould, J.; Steinberg, S.M.; Liewehr, D.J.; Yokokawa, J.; Tsang, K.Y.; Surawski, R.J.; Scott, T.; Camphausen, K. 2006: Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(16): 4983-4988

Tejada, M.L.; Yu, L.; Dong, J.; Jung, K.; Meng, G.; Peale, F.V.; Frantz, G.D.; Hall, L.; Liang, X.; Gerber, H.-P.; Ferrara, N. 2006: Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(9): 2676-2688

Bergman, F.; Linder, E. 1958: Tumor-forming amyloidosis of the lung. Journal of Thoracic Surgery 35(5): 628-637

Kamburov, I.; Astrug, A.; Dachev, A. 1955: Tumor-forming form of pulmonary stasis. Suvremenna Meditsina 6(7): 89-96

Takashima, T.; Onoda, N.; Ishikawa, T.; Koyama, T.; Inaba, M.; Nishizawa, Y.; Nakatani, T.; Wakasa, K.; Hirakawa, K. 2004: Tumor-forming idiopathic retroperitoneal fibrosis: report of a case. Surgery Today 34(4): 374-378

Althoff, H.; Nagel, W. 1955: Tumor-forming leukosis and its evaluation. Helvetica Paediatrica Acta 10(3): 342-368

Ziambaras, K.; Dagogo-Jack, S. 1999: Tumor-grade hyperprolactinemia induced by multiple medications in the setting of renal failure. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 5(3): 139-142

Yang, L.; Carbone, D.P. 2004: Tumor-host immune interactions and dendritic cell dysfunction. Advances in Cancer Research 92: 13-27

Montel, V.; Pestonjamasp, K.; Mose, E.; Tarin, D. 2005: Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts. Differentiation; Research in Biological Diversity 73(2-3): 88-98

Scott, K.G.; Stone, R.S. 1951: Tumor-host studies. III. Alteration of thyroid, skin, blood, and tumor uptake of I131-tagged diiodotyrosine in rats by transplanted tumors. Cancer 4(2): 345-352

Laviano, A.; Cascino, A.; Muscaritoli, M.; Fanfarillo, F.; Rossi Fanelli, F. 2003: Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease. Advances in Experimental Medicine and Biology 527: 363-366

Jensen, V.G.H.; Hovendal, C.P.; Karstoft, J. 2006: Tumor-induced colocolonic invagination in an adult. Ugeskrift for Laeger 168(38): 3228-3229

Castilla, M.A.; Neria, F.; Renedo, G.; Pereira, D.S.; González-Pacheco, F.R.; Jiménez, S.; Tramón, P.; Deudero, J.J.P.; Arroyo, M.V.A.; Yagüe, S.; Caramelo, C. 2004: Tumor-induced endothelial cell activation: role of vascular endothelial growth factor. American Journal of Physiology. Cell Physiology 286(5): C1170-C1176

Tartaglia, F.; Minisola, S.; Sgueglia, M.; Blasi, S.; Brunelli, D.; Degli Effetti, E.; Maturo, A.; Cola, A.; Custureri, F.; Campana, F.P. 2006: Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report. Il Giornale di Chirurgia 27(1-2): 9-13

Peters, C.M.; Ghilardi, J.R.; Keyser, C.P.; Kubota, K.; Lindsay, T.H.; Luger, N.M.; Mach, D.B.; Schwei, M.J.; Sevcik, M.A.; Mantyh, P.W. 2005: Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Experimental Neurology 193(1): 85-100

Gerlach, H. 2005: What is evidence-based?. Krankenpflege Journal 43(1-3): 54-55

Kaul, M.; Silverberg, M.; Dicarlo, E.F.; Schneider, R.; Bass, A.R.; Erkan, D. 2007: Tumor-induced osteomalacia. Clinical Rheumatology 26(9): 1575-1579

Bhattacharyya, S.; Mandal, D.; Sen, G.Sankar.; Pal, S.; Banerjee, S.; Lahiry, L.; Finke, J.H.; Tannenbaum, C.S.; Das, T.; Sa, G. 2007: Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Research 67(1): 362-370

Fukumoto, S. 2005: Tumor-induced rickets/osteomalacia. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 10): 523-528

Bittner, J.J. 1952: Tumor-inducing properties of the mammary tumor agent in young and adult mice. Cancer Research 12(7): 510-515

Tronchet, J. 1960: Tumor-induction in Cuscuta gronovii Willd plantlet by colchicine and by a tegmental inhibitor of germination and growth. a need for "conditioning"). Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 250: 1546-1548

Macchetti, A.H.; Marana, H.R.C.; Silva, J.ão.S.; de Andrade, J.M.; Ribeiro-Silva, A.; Bighetti, S.ér. 2006: Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics 61(3): 203-208

Parmiani, G. 2005: Tumor-infiltrating T cells--friend or foe of neoplastic cells?. New England Journal of Medicine 353(25): 2640-2641

Alvaro-Naranjo, Tás.; Lejeune, Mène.; Salvadó-Usach, M.T.; Bosch-Príncep, Rón.; Reverter-Branchat, G.; Jaén-Martínez, Jín.; Pons-Ferré, L.E. 2005: Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leukemia and Lymphoma 46(11): 1581-1591

Grabenbauer, G.G.; Lahmer, G.; Distel, L.; Niedobitek, G. 2006: Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(11 Part 1): 3355-3360

Preynat-Seauve, O.; Schuler, P.; Contassot, E.; Beermann, F.; Huard, B.; French, L.E. 2006: Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection. Journal of Immunology 176(1): 61-67

Mao, Y.-y.; Chen, H.-z.; Xie, X.; Ye, D.-f.; Lü, W.-g. 2004: Tumor-infiltrating dendritic cells in epithelial ovarian carcinoma and correlation with the expression of vascular endothelial growth factor. Zhonghua Fu Chan Ke Za Zhi 39(10): 693-697

Osada, T.; Nagawa, H.; Shibata, Y. 2004: Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor. Journal of Immune Based Therapies and Vaccines 2(1): 7

Hsiao, Y.-W.; Liao, K.-W.; Hung, S.-W.; Chu, R.-M. 2004: Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. Journal of Immunology 172(3): 1508-1514

Taylor, R.C.; Patel, A.; Panageas, K.S.; Busam, K.J.; Brady, M.S. 2007: Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(7): 869-875

Von Euler, H.; Von Euler, B.; Hasselquist, H. 1955: Tumor-inhibiting and carcinogenic effect of nitrogen-containing substances. Zeitschrift für Krebsforschung 60(3): 279-282

Weisberger, A.S.; Pensky, J. 1957: Tumor-inhibiting effects derived from an active principle of garlic (Allium sativum). Science 126(3283): 1112-1114

Dahan, M.H.; Lyle, L.N.; Wolfsen, A.; Chang, R.J. 2004: Tumor-level serum testosterone associated with human immunodeficiency virus lipodystrophy syndrome. Obstetrics and Gynecology 103(5 Part 2): 1094-1096

Guarnaccia, E.; Scebba, G. 1962: Tumor-like adenomegaly of the minor salivary glands. La Clinica Otorinolaringoiatrica 14: 112-126

Glauser, O. 1955: Tumor-like amyloid of the lungs; contribution to dystrophic ossification. Schweizerische Zeitschrift für Pathologie und Bakteriologie. Revue Suisse de Pathologie et de Bacteriologie 18(1): 42-65

Rakocevic-Stojanovic, V.; Skender-Gazibara, M.; Grujicic, D.; Lavrnic, D.; Dackovic, J.; Vujic, A.; Apostolski, S. 2006: Tumor-like brain lesions in a patient with Hashimoto encephalopathy and hereditary motor and sensory neuropathy. Acta Myologica: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology 25(1): 38-39

Setala, K.; Lundbom, S.; Holsti, P. 1958: Tumor-like changes in slime mold Physarum polycephalum induced by carcinogens and by non-ionizing surface active carcinogenic substances. Zeitschrift für Krebsforschung 62(3): 245-269

Griepentrog, F. 1962: Tumor-like changes in the thyroid gland in chronic toxicological animal experiments with thiurams. Beitrage Zur Pathologischen Anatomie und Zur Allgemeinen Pathologie 126: 243-255

Goldstein, M.B.; Dragon, V. 1960: Tumor-like changes of the bladder mucosa after radiotherapy for cervical cancer. Zeitschrift für Urologie 53: 491-498

Oppel, O. 1956: Tumor-like degenerative processes of the conjunctiva. Klinische Monatsblatter für Augenheilkunde und für Augenarztliche Fortbildung 128(2): 145-158

Knoth, W.; Krause, S.; Knoll, K.H. 1955: Tumor-like fungus disease caused by non-ascoporogenic yeast. Dermatologica 111(6): 357-366

Gol'mberg, V.V. 1954: Tumor-like growth of the salivary gland of the tongue. Vestnik Otorinolaringologii 16(6): 72-73

Arnold, K. 1962: Tumor-like histiocytic nodes in chronic prostatitis. Zeitschrift für Urologie 55: 219-223

Levkoeva, E.F. 1959: Tumor-like hyperplastic processes in the conjunctiva. Arkhiv Patologii 21(10): 3-7

Fliegelman, M.T.; Loveman, A.B. 1952: Tumor-like keratoses; report of a case. A.M.A. Archives of Dermatology and Syphilology 66(3): 353-357

Uhl, M.; Adler, C.-P.; Herget, G.W. 2004: Tumor-like lesions. Der Radiologe 44(10): 1013-1022; Quiz: 1023-1024

Jelsma, F.; Ross, P.J. 1963: Tumor-like lesions of the calvaria (due to general disease processes). American Surgeon 29: 247-255

Kost, E.A. 1952: Tumor-like leukemias. Terapevticheskii Arkhiv 24(6): 59-65

Grosse, H. 1958: Tumor-like lymphogranulomatosis of the lungs following aspiration of a rubber eraser sometime previously. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 98(5-6): 308-311

Roidis, N.; Zachos, V.; Basdekis, G.; Hantes, M.; Khaldi, L.; Malizos, K. 2007: Tumor-like meniscal cyst. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 23(1): 111.E1-6

Lee, S.N.; Cho, M.-S.; Kim, S.C.; Han, W.S. 2005: Tumor-like multilocular cystic endosalpingiosis of the uterine serosa: possible clinical and radiologic misinterpreted. Acta Obstetricia et Gynecologica Scandinavica 84(1): 98-99

Caroli, E.; Salvati, M.; Ferrante, L. 2006: Tumor-like multiple sclerosis: report of four cases and literature review. Tumori 92(6): 559-562

Minnigerode, B. 1956: Tumor-like pachyderma laryngis. Hno 6(2): 50-52

Cohen, H. 1957: Tumor-like proliferations of lymphoid tissue; occurrence in deltoid muscle and mediastinum. Journal of the Mount Sinai Hospital new York 24(6): 750-760

Pimentel, J.C. 1958: Tumor-like pulmonary aspergillosis (pulmonary aspergilloma): contribution to its anatomical and pathological picture and to its pathogenesis. Medicina Contemporanea 76(6): 241-268

Surat, V.S. 1956: Tumor-like syndrome in hypertensive disease with atherosclerosis of cerebral blood vessels. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 56(6): 464-466

Pimentel, J.C. 1958: Tumor-like type of pulmonary aspergillosis (pulmonary aspergilloma); anatomopathological study of 4 cases & discussion on its pathogenesis. Gazeta Medica Portuguesa 11(4): 455-472

Gosepath, P.; Hassenpflug, K.H. 1962: Tumor-like ulcerative eosinophilic granuloma of the under side of the tongue. Zeitschrift für Haut- und Geschlechtskrankheiten 33: 118-123

Bargheer, R.; Erbsloeh, J. 1960: Tumor-like vascular neoplasms of the cervix uteri. Zeitschrift für Geburtshilfe und Gynakologie 155: 81-86

Witz, I.P. 2006: Tumor-microenvironment interactions: the selectin-selectin ligand axis in tumor-endothelium cross talk. Cancer Treatment and Research 130: 125-140

Ballini, I.; Guimaraes, J.P. 1962: Tumor-producing capacity of transplanted lung and spleen taken from Yoshida sarcoma bearing rats. Experientia 18: 186-187

Fark, G. 1962: Tumor-promoting action of a fat-rich diet. Arzneimittel-Forschung 12: 1036-1037

Holsti, P. 1959: Tumor-promoting effects in mouse skin; comparison between oleic acid, sorbitan mono-oleate (span 80), and polyoxyethylene sorbitan mono-oleate (tween 80). Annales Medicinae Experimentalis et Biologiae Fenniae 37: 212-215

Rüffer, J.U. 2003: Tumor-related fatigue - an underestimated problem. Onkologie 26(5): 423-424

Hiraoka, K.; Kimura, T.; Logg, C.R.; Kasahara, N. 2006: Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(23): 7108-7116

Shen, F.-b.; Chang, J.-h.; Yang, C.; Li, J.; Guo, Y.; Yi, B.; Li, H.-x.; Ye, X.-f.; Wang, L. 2007: Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection. Sichuan da Xue Xue Bao. Yi Xue Ban 38(1): 31-34

Sasson, L. 1960: Tumor-simulating deformities after subtotal gastrectomy. a study of the problems of the deformities of the postoperative stomach produced by operative distortions which give the appearance of tumor growths. JAMA 174: 280-283

Dolan, B.P.; Gibbs, K.D.; Ostrand-Rosenberg, S. 2006: Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. Journal of Immunology 176(3): 1447-1455

Vuylsteke, R.J.C.L.M.; Molenkamp, B.G.; van Leeuwen, P.A.M.; Meijer, S.; Wijnands, P.G.J.T.B.; Haanen, J.B.A.G.; Scheper, R.J.; de Gruijl, T.D. 2006: Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage i melanoma patients is associated with high myeloid dendritic cell content. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(9): 2826-2833

Winter, H.; van den Engel, N.K.; Poehlein, C.H.; Hatz, R.A.; Fox, B.A.; Hu, H.-M. 2007: Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor. Journal of Translational Medicine 5: 14

Allison, J.P.; McIntyre, B.W.; Bloch, D.; Allison, J.P.; McIntyre, B.W.; Bloch, D. 2005: Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982. Journal of Immunology 174(3): 1144-1151

Prehn, R.T. 1963: Tumor-specific antigens and the homograft reaction. American Journal of Surgery 105: 184-191

Sitdikova, S.M.; Amandzholov, B.S.; Sel'chuk, V.Y.; Donenko, F.V. 2003: Tumor-specific changes in mouse serum during Ehrlich carcinoma growth. Bulletin of Experimental Biology and Medicine 135(6): 576-579

Biesele, J.J. 1958: Tumor-specific cytotoxicity of antitumor agents. Annals of the new York Academy of Sciences 76(3): 530-533

Blumenthal, R.D.; Leone, E.; Goldenberg, D.M. 2003: Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy. Anticancer Research 23(6c): 4613-4619

Sloan, E.K.; Pouliot, N.; Stanley, K.L.; Chia, J.; Moseley, J.M.; Hards, D.K.; Anderson, R.L. 2006: Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Research: Bcr 8(2): R20

Rydén, L.; Jirström, K.; Bendahl, P.är.-O.; Fernö, M.år.; Nordenskjöld, B.; Stål, O.; Thorstenson, S.; Jönsson, P.-E.; Landberg, G.ör. 2005: Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(21): 4695-4704

Ruan, X.; Li, Y.; Li, J.; Gong, D.; Wang, J. 2006: Tumor-specific gene expression patterns with gene expression profiles. Science in China. Series C Life Sciences 49(3): 293-304

Ogura, M.; Shibata, T.; Harada, H.; Hiraoka, M. 2006: Tumor-specific gene therapy strategy for renal cell carcinomas. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 2): 672-675

Downing, J.R.; Mullighan, C.G. 2006: Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. HEMATOLOGY. American Society of Hematology. Education Program 2006: 118-122; 508

Corin, I.; Di Giacomo, M.C.; Lastella, P.; Bagnulo, R.; Guanti, G.; Simone, C. 2006: Tumor-specific hyperactive low-molecular-weight cyclin e isoforms detection and characterization in non-metastatic colorectal tumors. Cancer Biology and Therapy 5(2): 198-203

Kohlgraf, K.G.; Gawron, A.J.; Higashi, M.; VanLith, M.L.; Shen, X.; Caffrey, T.C.; Anderson, J.M.; Hollingsworth, M.A. 2004: Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1). Cancer Immunology Immunotherapy: Cii 53(12): 1068-1084

Kim, H.; Kwon, Y.M.; Kim, J.S.; Lee, H.; Park, J.-H.; Shim, Y.M.; Han, J.; Park, J.; Kim, D.-H. 2004: Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(12): 2363-2370

Righini, C.A.; de Fraipont, F.; Timsit, J.-F.ço.; Faure, C.; Brambilla, E.; Reyt, E.; Favrot, M.-C. 2007: Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(4): 1179-1185

Alvisi, G.; Poon, I.K.H.; Jans, D.A. 2006: Tumor-specific nuclear targeting: promises for anti-cancer therapy?. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer ChemoTherapy 9(1-2): 40-50

Schewe, D.M.; Leupold, J.H.; Boyd, D.D.; Lengyel, E.R.; Wang, H.; Gruetzner, K.U.; Schildberg, F.W.; Jauch, K.W.; Allgayer, H. 2003: Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(6): 2267-2276

Pitts, F.W.; Haskin, M.E.; Riggs, H.E.; Groff, R.A. 1962: Tumor-stain in cerebrovascular disease. Transactions of the American Neurological Association 87: 16-19

Löffek, S.; Zigrino, P.; Mauch, C. 2006: Tumor-stroma interactions: their role in the control of tumor cell invasion and metastasis. Journal der Deutschen Dermatologischen Gesellschaft 4(6): 496-502; Quiz 503

Fang, B.; Roth, J.A. 2003: Tumor-suppressing gene therapy. Cancer Biology and Therapy 2(4 Suppl 1: S115-S121

Dong, W.-J.; Hu, H.-T.; Gong, H.-L. 2005: Tumor-suppression effect of polyactin a combined with GM-CSF, TNF-alpha and IL-4 on cord blood mononuclear cells. Zhong Nan da Xue Xue Bao. Yi Xue Ban 30(5): 553-557

Gao, J.Q.; Alexandre, L.S.; Tsuda, Y.; Katayama, K.; Eto, Y.; Sekiguchi, F.; Mizuguchi, H.; Hayakawa, T.; Nakayama, T.; Yoshie, O.; Tsutsumi, Y.; Mayumi, T.; Nakagawa, S. 2004: Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors. Die Pharmazie 59(3): 238-239

Xu, X.-C. 2007: Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Letters 253(1): 14-24

Sun, L. 2004: Tumor-suppressive and promoting function of transforming growth factor beta. Frontiers in Bioscience: a Journal and Virtual Library 9: 1925-1935

Reimer, P. 2004: Tumor-targeted MR contrast agents: hype or future hope?. Radiology 231(1): 1-2

Chiu, S.-J.; Ueno, N.T.; Lee, R.J. 2004: Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. Journal of Controlled Release: Official Journal of the Controlled Release Society 97(2): 357-369

Ogris, M.; Wagner, E. 2002: Tumor-targeted gene transfer with DNA polyplexes. Somatic Cell and Molecular Genetics 27(1-6): 85-95

Xue, F.; Dong, C.-Y.; Su, Y.; Zhu, H.; Ling, W.; Liu, Y.; Xu, H.; Xiao, W.; Zhou, S.; Qi, Y.-P. 2005: Tumor-targeted therapy with a conditionally replicating mutant of HSV-1 induces regression of xenografted human hepatomas. Cancer Biology and Therapy 4(11): 1234-1239

Hamada, H. 2003: Tumor-targeting gene therapy: Ras-dependent oncolytic viral vectors. Uirusu 53(2): 195-199

Miao, Y.; Hoffman, T.J.; Quinn, T.P. 2005: Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model. Nuclear Medicine and Biology 32(5): 485-493

Brack, S.S.; Silacci, M.; Birchler, M.; Neri, D. 2006: Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(10): 3200-3208

Steno, J.; Malácek, M.; Bízik, I. 2004: Tumor-third ventricular relationships in supradiaphragmatic craniopharyngiomas: correlation of morphological, magnetic resonance imaging, and operative findings. Neurosurgery 54(5): 1051-1058; Discussion: 1058-1060

Shomaf, M.S. 2002: Tumor-to-tumor metastases to follicular adenoma of thyroid: case report and review of the literature. Annals of Saudi Medicine 22(3-4): 224-226

Stanesco, V.; Ionesco, V.; Florea, I.; Stanesco, R. 1965: Tumoral Acromegalic Gigantism in 2 Boys. Annales de Pediatrie 12: 123-131

Wegmann, R.; Corcos, V.; Albano, O.; Julien, C. 1964: Tumoral and Gastric Histoenzymology in a Zollinger-Ellison Patient. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 40: 1737-1747

Giraud, P.; Bernard, R.; Vigouroux, R.; Espinas, J.; Mariani, R. 1964: Tumoral and Pseudotumoral Hydrocephalus in Infants. (Apropos of 19 Cases). Les Cahiers du College de Medecine des Hopitaux de Paris 5: 749-751

Reddy, C.R.; Rao, B.S. 1964: Tumoral Calcinosis. Journal of the Indian Medical Association 43: 336-337

Sokolov, L.K. 1964: Tumoral Gastritis. (Review of the Literature). Sovetskaia Meditsina 27: 81-88

Pato, A.; Lorenzo González, J.R.; Cimas Hernando, I. 2005: Tumoral Parkinsonism. Neurologia 20(8): 431

Gautheret, R.J. 1964: Tumoral Phenomena in Plants: their relation to the Problem of Cancer. Annales Pharmaceutiques Francaises 22: 147-158

Van Baren, N.; Bonnet, M.-C.; Dréno, B.; Khammari, A.; Dorval, T.; Piperno-Neumann, S.; Liénard, D.; Speiser, D.; Marchand, M.; Brichard, V.G.; Escudier, B.; Négrier, S.; Dietrich, P.-Y.; Maraninchi, D.; Osanto, S.; Meyer, R.G.; Ritter, G.; Moingeon, P.; Tartaglia, J.; van der Bruggen, P.; Coulie, P.G.; Boon, T. 2005: Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(35): 9008-9021

Merlet, S.; Dandurand, M.; Elmajaoui, S.; Joujoux, J.-M.; Ligeron, C.; Michel, B.; Stoebner, P.-E.; Meunier, L. 2006: Tumoral and pilotropic mycosis fongoides without mucin: evolution towards a pustulous erythroderma. Annales de Dermatologie et de Venereologie 133(2): 149-152

Kuss, R.; Mathieu, F. 1962: Tumoral and radiotherapeutic cystitis. La Revue du Praticien 12: 3041

Havas, L.J.; Heusner, A. 1951: Tumoral and teratological reactions of a tetraploid tomato to Phytomonas tumefaciens Smith and Townsend. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 232(18): 1695-1696

Kerbrat; Cellerier 1954: Tumoral bronchopulmonary actinomycosis. Journal Francais de Medecine et Chirurgie Thoraciques 8(5): 555-561

Le Stanc, E.; Vilain, D.; Tainturier, C. 2004: Tumoral calcinosis appearances on skeletal scintigraphy. Clinical Nuclear Medicine 29(12): 821-822

Pilloni, L.; Fanni, D.; Nardello, O.; Cagetti, M.; Faa, G. 2004: Tumoral calcinosis in a Sardinian patient mimicking hydatid disease: a case report. Pathologica 96(6): 470-474

Shibuya, S.; Kawaguchi, Y.; Arima, N.; Yamamoto, T.; Dobashi, H.; Tokuda, M. 2006: Tumoral calcinosis in bilateral facet joints of the lumbar spine in scleroderma. Case report. Journal of Neurosurgery. Spine 5(5): 451-454

Bittmann, S.; Ulus, H. 2005: Tumoral calcinosis in childhood. Praxis 94(34): 1309-1311

Tong, M.K.H.; Siu, Y.P. 2004: Tumoral calcinosis in end stage renal disease. Postgraduate Medical Journal 80(948): 601

Hammoud, S.; McCarthy, E.F.; Weber, K. 2005: Tumoral calcinosis in infants: a report of three cases and review of the literature. Clinical Orthopaedics and Related Research 2005(436): 261-264

Teng, A.L.; Robbin, M.R.; Furey, C.G.; Easley, S.E.; Abdul-Karim, F.W.; Bohlman, H.H. 2006: Tumoral calcinosis in the cervical spine in a patient with CREST syndrome. A case report. Journal of Bone and Joint Surgery. American Volume 88(1): 193-197

Aydin, A.; Tuncer, S.; Erer, M.; Bilgic, B. 2004: Tumoral calcinosis infiltrating the biceps brachii tendon - excision and reconstruction with allograft: a case report. Journal of Hand Surgery 29(2): 170-172

Fontaine, R.; Frank, P.; Stoll, G.; Wilhelm-Mathis, L. 1952: Tumoral calcinosis much improved by thymo-parathyroidectomy with a study of minimal calcium rates. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 28(29): 1211-1217

Dimitroulis, G. 2004: Tumoral calcinosis of the articular disc of the temporomandibular joint: a rare entity. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 62(12): 1551-1553

Sharma, M.; Sinha, R.; Hussey, K.; Fouyas, I.P. 2005: Tumoral calcinosis of the filum terminale. Neurosurgery 57(3): E596; Discussion E596

Bittmann, S.; Günther, M..W.; Ulus, H. 2003: Tumoral calcinosis of the gluteal region in a child: case report with overview of different soft-tissue calcifications. Journal of Pediatric Surgery 38(8): E4-E7

El Khatib, K.; Danino, A.; Malka, G.; Taobane, H. 2004: Tumoral calcinosis of the plantar forefoot: a case report and review of the literature. Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur 90(5): 471-474

Giardina, F.; Sudanese, A.; Bertoni, F.; Guerra, E.; Paderni, S. 2004: Tumoral calcinosis of the popliteal space. Orthopedics 27(10): 1104-1107

Jacob, J.J.; Thomas, N.; Seshadri, M.S. 2007: Tumoral calcinosis of the scalp: An unusual site for a rare tumor. Laryngoscope 117(1): 179-180

Inamadar, A.C.; Palit, A.; Yelikar, B.R. 2004: Tumoral calcinosis with cutaneous involvement in an elderly man. Dermatology 209(3): 246-247

Rambani, R.; Dhillon, M.S.; Aggarwal, R. 2003: Tumoral calcinosis with unusual presentation. A case report. Acta Orthopaedica Belgica 69(4): 368-372

Joshi, S.R.; Tekwani, D.; Nagle, S.B.; Basu, S.K. 2006: Tumoral calcinosis--clinicopathological study of five cases. Indian Journal of Pathology and Microbiology 49(3): 433-435

Huang, Y.-T.; Chen, C.-Y.; Yang, C.-M.; Yao, M.-S.; Chan, W.P. 2006: Tumoral calcinosis-like metastatic calcification in a patient on renal dialysis. Clinical Imaging 30(1): 66-68

Agnew, C.H. 1961: Tumoral calcinosis. a radiologic teaching method. Journal of the Kansas Medical Society 62: 100-102

Barton, D.L.; Reeves, R.J. 1961: Tumoral calcinosis. Report of three cases and review of the literature. American Journal of Roentgenology Radium Therapy and Nuclear Medicine 86: 351-358

Seyahi, A.; Atalar, A.C.; Ergin, H.K. 2006: Tumoral calcinosis: Clinical and biochemical aspects of a patient treated with vinpocetine. European Journal of Internal Medicine 17(6): 436-438

De Beur, S.M.J. 2005: Tumoral calcinosis: a look into the metabolic mirror of phosphate homeostasis. Journal of Clinical Endocrinology and Metabolism 90(4): 2469-2471

Buch, A.C.; Panicker, N.K.; Gore, C.R. 2006: Tumoral calcinosis: a series of six cases with review of pathogenesis and histopathological diagnosis. Indian Journal of Pathology and Microbiology 49(2): 182-187

Olsen, K.M.; Chew, F.S. 2006: Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics: a Review Publication of the Radiological Society of North America Inc 26(3): 871-885

Kisembo, H.; Kiguli-Malwadde, E.; Kawooya, M.G. 2000: Tumoral calcinosis: report of nine cases. East African Medical Journal 77(10): 574-575

Dagregorio, G.; Saint-Cast, Y. 2006: Tumoral calcium pyrophosphate dihydrate crystal deposition in the fifth metacarpophalangeal region. Orthopedics 29(2): 161-162

Kamalidehghan, B.; Houshmand, M.; Panahi, M.S.S.; Abbaszadegan, M.R.; Ismail, P.; Shiroudi, M.B. 2006: Tumoral cell mtDNA approximately 8.9 kb deletion is more common than other deletions in gastric cancer. Archives of Medical Research 37(7): 848-853

Rud, H. 1953: Tumoral counterindications against resection of rectum carcinoma. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 24(8): 341-344

Rivero-Celada, D.; Carcavilla-Loncán, L.I.; Marín-Cárdenas, M.A.; Cantero-Antón, J.M.; Alfaro-Torres, J.; Duato-Jané, F.; Eiras-Ajuria, J. 2006: Tumoral degeneration occurring over a non-healing meningocele. Report of two cases. Neurocirugia 17(6): 532-537

Ishida, H.; Ohsawa, T.; Nakada, H.; Yokoyama, M.; Inokuma, S.; Shirakawa, K.; Yamada, H.; Hashimoto, D. 2004: Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 883-887

Ilie, B. 1963: Tumoral disease of mice transmissible by cell-free material. II. Evolution of the disease toward a form of cytemic or acytemic tumoral reticulosis. Studii Si Cercetari de Inframicrobiologie 14: 355-361

Kempeneers, J. 1957: Tumoral disorders of the ceco-ascending colon. Revue Medicale de Liege 12(21): 608-618

Maroto, J. 1959: Tumoral diverticulitis of the sigmoid colon. Revista Espanola de Las Enfermedades del Aparato Digestivo y de la Nutricion 18(1): 191-194

Michael, M.; Doherty, M.M. 2005: Tumoral drug metabolism: overview and its implications for cancer therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(1): 205-229

Alajouanine, T.; Rondot, P.; Laplane, D.; Castaigne, P. 1959: Tumoral epilepsy. La Revue du Praticien 9(13): 1409

Chavany, J.A.; Klein, M.R. 1951: Tumoral epilepsy originating from the inferior cerebral trunk. La Presse Medicale 59(6): 102-104

Sitges, A. 1962: Tumoral epiploitis in gynecology. Revista Espanola de Obstetricia y Ginecologia 21: 97-108

Offret, G.; Juge, P. 1955: Tumoral exophthalmia without orbital tumors. Bulletin des Societes d'Ophtalmologie de France 10: 737-739

Appelmans, M.; Michiels, J.; Mousset, C. 1959: Tumoral exophthalmos in children. Results of the P32 test. Bulletin de la Societe Belge d'Ophtalmologie 123: 583-594

Roldán, G.; Delgado, L.ía.; Musé, I.M. 2006: Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer. Cancer Biology and Therapy 5(5): 505-510

Toniolo 1949: Tumoral features of hypertrophic gastritis in an alcoholic patient. La Radiologia Medica 35(10): 833

Figueiredo, E.Gadelha.; Fonoff, E.; Gomes, M.; Macedo, E.; Marino Júnior, R. 2003: Tumoral form of aspergillosis in central nervous system (cerebral aspergilloma): case report. Sao Paulo Medical Journal 121(6): 251-253

Longo, O.F.; Coppari, G.G. 1959: Tumoral form of chronic unspecific epiploitis. Boletines y Trabajos. Sociedad de Cirugia de Buenos Aires 43: 386-390

Carpentier, P.J. 1956: Tumoral form of dysontogenesis of the gonads. Bruxelles Medical 36(49): 2341-2349

Hewitt, J.; Richon, L.; Ossipowski, B. 1955: Tumoral form of lymphatic leukemia; probable cutaneous point of departure. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 3: 296-297

Trucy, H. 1959: Tumoral form of segmental colitis of the transverse colon. Bordeaux Chirurgical 1: 26-29

Lapeyrere, J.; Moreau, J.; Malecaze, A. 1961: Tumoral form of ulcer of the transverse colon. Archives des Maladies de l'Appareil Digestif et des Maladies de la Nutrition 50: 833-835

Shchupak, N.B. 1957: Tumoral formations of tuberculous etiology in the abdominal cavity. Terapevticheskii Arkhiv 29(4): 41-47

Ponomareva, E.D. 1958: Tumoral forms of acute leukemia. Terapevticheskii Arkhiv 30(5): 71-77

Truc; Guillaume; Rapp 1955: Tumoral forms of tuberculosis of the bladder. Journal d'Urologie Medicale et Chirurgicale 61(6): 422-424

Vidal-Colomer, E. 1958: Tumoral gastritis in the 1st stages and its malignant transformation. Medicina Espanola 39(277): 160-166

Puente Duany, N. 1949: Tumoral lesions of the hair follicles. II. Malignant tricho-epitheliomas. Archivos Cubanos de Cancerologia 8(7-9): 189-229

Puente Duany, N. 1951: Tumoral lipofibroadenosis of the breast. Revista Medica Cubana 62(12): 900-907

Bonnetblanc, J-Marie.; Bedane, C.; Fayol, J.; Labrousse, Fçois. 2006: Tumoral macroglobulinosis of the skin: In situ release of IgM. Acta Dermato-Venereologica 86(1): 63-64

Irigoyen Oyarzabal, A.M.; Amiguet García, J.A.; López Vivanco, G.; Genollá Subirats, J.; Muñoz Villafranca, M.C.; Ojembarrena Martínez, E.; Liso Irurzun, P. 2003: Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer. Gastroenterologia y Hepatologia 26(10): 624-629

Gómez Rubio, M.; de Cuenca Morón, B.; Domínguez, M. 2005: Tumoral markers in liver cirrhosis and hepatocellular carcinoma. Gastroenterologia y Hepatologia 28(5): 308

Bao, D.-m.; Wang, Z.; Shen, D.-h. 2006: Tumoral mass of left waist. Zhonghua Bing Li Xue Za Zhi 35(6): 375-376

Oztürk, A.; Yalçinkaya, U.; Ozkan, Y.ük.; Atici, T. 2007: Tumoral mass on a phalangeal bone in a 19-year-old. Clinical Orthopaedics and Related Research 458: 229-234

Gelati, M.; Visioli, O. 1960: Tumoral medullary metastases in lymphoid leukemia, and lymphatic leukemoid reactions in the course of malignant neoplasms. Giornale di Clinica Medica 41: 1661-1674

Ng, S.H.; Chave, T.A. 2006: Tumoral melanosis as a manifestation of a completely regressed primary melanoma with metastases. British Journal of Dermatology 155(3): 627-628

Reymond, A. 1953: Tumoral meningitis. Oncologia 6(2): 85-91

Arismendi-Morillo, G.; Castellano, A. 2005: Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. a transmission electron microscopy study. Journal of Neuro-Oncology 73(3): 211-217

Oréga, M.; Couitchère, L.; Yao, A.; Cisse, L.; Enoh, J.; Niangue, M.; Oulai, M.; Andoh, J. 2004: Tumoral pathology in foreign children in Abidjan. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 11(2): 156

Negri, L.; Smorlesi, L. 1952: Tumoral pathology of the epididymis and its criticism. Archivio "de Vecchi" Per l'Anatomia Patologica E la Medicina Clinica 18(3): 855-873

Batzenschlager, A.; Dorner, M.; Weill-Bousson, M. 1963: Tumoral pathology of thorotrast in man (Review of literature--Personal statistical findings). Oncologia 16: 28-63

Dehen, L.; Vilmer, C. 2006: Tumoral presentation of genital herpes in a female HIV-positive patient. Annales de Dermatologie et de Venereologie 133(4): 393-394

Lebedinskaia, S.I.; Solov'ev, A.A. 1959: Tumoral processes and characteristics of their pathogenesis. Vestnik Akademii Meditsinskikh Nauk SSSR 14(7): 42-50

Biendara, E. 1953: Tumoral radium therapy of inner laryngeal carcinoma after total excision of the thyroid cartilage. Zeitschrift für Laryngologie Rhinologie Otologie und ihre Grenzgebiete 32(11): 658-664

Calleja Kempin, J.; Colón Rodríguez, A.; Muro de la Fuente, A.; Clemente Ricote, G.; Prieto Martín, M.; Santos Castro, L.; Matilla Peña, A.; Bañares Cañizares, R.; Martín Baena, D. 2005: Tumoral response factors after radiofrequency ablation of hepatocellular carcinoma in cirrhotic liver. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 97(10): 688-698

Herrero Ducloux, K.; Niedfeld, G. 1961: Tumoral reticulopathies. Brill-Symmers disease and megakaryocytic myelosis. Contribution to the casuistics. Prensa Medica Argentina 48: 269-278

Mahé, E.; Bouscarat, F.; Descamps, V.; Crickx, B. 2003: Tumoral rhinophyma. Presse Medicale 32(18): 844

Palacio, J.; Dreyer, M.S.; Navarret, E.E.; Pedacce, E.A.; Lloveras, J. 1962: Tumoral silicosis and its relation to silicotuberculosis. Prensa Medica Argentina 49: 1667-1679

Mărgăritescu, C.; Raica, M.; Simionescu, C.; Mogoantă, L.; Surpăţeanu, M.; Jaubert, F.; Bogdan, F. 2005: Tumoral stroma of salivary pleomorphic adenoma -- histopathological, histochemical and immunohistochemical study. Romanian Journal of Morphology and Embryology 46(3): 211-223

Terracol, J.; Guerrier, Y. 1952: Tumoral syndrome of glomus jugulare. La Presse Medicale 60(33): 715-716

Croce, J.; Dejean, C. 1954: Tumoral syndrome of the floor of the orbit. Montpellier Medical 45(5): 450-452

Albertengo, J.B. 1952: Tumoral syndrome of the foramen magnum. Anales de Cirugia 17(3-4): 171-184

Boltanski, E.; Meyer-Heine, A.; Dubois, J.; Sebire, C. 1958: Tumoral type of hematoma of the rectus abdominis during anticoagulant therapy of myocardial infarct. Archives des Maladies de l'Appareil Digestif et des Maladies de la Nutrition 47(11): 1232-1236

Fideleff, H.L.; Azaretzky, M.; Boquete, H.R.; Pujol, A.B.; Honfi, M.; Suárez, M.G.; Fideleff, G.; Giaccio, A.V. 2003: Tumoral versus non-tumoral hyperprolactinemia in children and adolescents: possible usefulness of the domperidone test. Journal of Pediatric Endocrinology and Metabolism: Jpem 16(2): 163-167

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2004: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Pathologica 96(1): 9-17

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2004: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part II: the list and a review. Pathologica 96(2): 52-94

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2004: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part IV: excerpta Ii. Pathologica 96(5): 436-463

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2005: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part IX: excerpta VIi. Pathologica 97(5): 343-360

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2004: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part V: excerpta IIi. Pathologica 96(6): 481-495

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2005: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part VII: excerpta V. Pathologica 97(2): 92-114

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2005: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part VIII: excerpta Vi. Pathologica 97(3): 141-157

Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2005: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part X: excerpta VIIi. Pathologica 97(6): 394-408

Zhang, L.; Pang, B.; Zhang, W.; Bai, W.; Yu, W.; Li, Y.; Hua, W.; Li, W.; Kou, C. 2018: Association Between Schizophrenia and DNA Demethylase Activity in Human Peripheral Blood Mononuclear Cells. Clinical Laboratory 2018(6): 10.7754/Clin.Lab.2018.180127

Caceres, J. 1954: Tumoration of the right lung. Revista de la Sanidad Militar del Peru 27(76): 22-31

Schuller, H.; Bolin, H.; Linder, E.; Stenram, U. 1962: Tumorforming amyloidosis of the lower respiratory system. Report of a case in the lung and a short review of the literature. Diseases of the Chest 42: 58-67

Lampert, P. 1958: Tumorforming atypical amyloidosis of the choroid plexus with invasion of the cerebral white matter. Journal of Neuropathology and Experimental Neurology 17(4): 604-611

Grace, J.T.; Lehoczky, A. 1959: Tumorhost relationship factors in man. Surgery 46(1): 238-246

Fregni, R.; De Poli, A. 1957: Tumori orbitoparanasali; studio clinico. Archivio italiano di otologia, rinologia e laringologia 68(Suppl 33): 1-333

Minton, J.P.; Ketcham, A.S.; Dearman, J.R. 1964: Tumoricidal Factor in Laser Radiation. Surgical Forum 15: 335-336

Reddy, L.Harivardhan.; Adhikari, J.Singh.; Dwarakanath, B.Srinirasa.Rao.; Sharma, R.Kumar.; Murthy, R.Ramachandra. 2006: Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice. Aaps Journal 8(2): E254-E262

Zavadil, M.; Feyreisl, J.; Krofta, L.; Jarolím, L. 2006: Tumoriform endometriosis of the urinary bladder in advanced pregnancy. Ceskoslovenska Patologie 42(2): 91-94

Hohlweg, U.; Dorn, A.; Hösel, M.; Webb, D.; Buettner, R.; Doerfler, W. 2004: Tumorigenesis by adenovirus type 12 in newborn Syrian hamsters. Current Topics in Microbiology and Immunology 273: 215-244

Tsuruo, T. 2005: Tumorigenesis facilitated by Pten deficiency in the skin: evidence of p53-Pten complex formation on the initiation phase. Cancer Science 96(6): 377

Hollander, C.F.; Zurcher, C.; Broerse, J.J. 2003: Tumorigenesis in high-dose total body irradiated rhesus monkeys--a life span study. Toxicologic Pathology 31(2): 209-213

Yin, H.; Bhattacharjee, D.; Roy, G.; Fujimoto, N.; Nakatani, T.; Ito, A. 2002: Tumorigenesis in infant C3H/HeN mice exposed to tritiated water (HTO). Journal of Radiation Research 43(4): 345-351

Damo, L.A.; Snyder, P.W.; Franklin, D.S. 2005: Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways. Molecular Carcinogenesis 42(2): 109-120

Ito, Y.; Evans, C.A. 1965: Tumorigenic Nucleic Acid Extracts from Tissues of a Transplantable Carcinoma, Vx7. Journal of the National Cancer Institute 34: 431-437

Moore, A.E. 1958: Tumorigenic activity of cultures. Annals of the new York Academy of Sciences 76(3): 497-505

Foley, G.E.; Handler, A.H. 1958: Tumorigenic activity of tissue cell cultures. Annals of the new York Academy of Sciences 76(3): 506-512

Martorell, F. 1951: Tumorigenic lymphedema. Angiology 2(5): 386-392

Esmaeili, A.; Schlatterer, K.; Demirhan, I.; Schlatterer, B.; Nauck, M.; Chandra, P.; Chandra, A. 2006: Tumorigenic potential and the molecular mechanism of the carcinogenic effect exerted by 2-nitroanisole. Anticancer Research 26(6b): 4203-4212

Ledwith, B.J.; Lanning, C.L.; Gumprecht, L.A.; Anderson, C.A.; Coleman, J.B.; Gatto, N.T.; Balasubramanian, G.; Farris, G.M.; Kemp, R.K.; Harper, L.B.; Barnum, A.B.; Pacchione, S.J.; Mauer, K.L.; Troilo, P.F.J.; Brown, E.R.; Wolf, J.J.; Lebronl, J.A.; Lewis, J.A.; Nichols, W.W. 2006: Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line. Developments in Biologicals 123: 251-263; Discussion: 265-266

Aonuma, M.; Iwahana, M.; Nakayama, Y.; Hirotani, K.; Hattori, C.; Murakami, K.; Shibuya, M.; Tanaka, N.G. 1998: Tumorigenicity depends on angiogenic potential of tumor cells: dominant role of vascular endothelial growth factor and/or fibroblast growth factors produced by tumor cells. Angiogenesis 2(1): 57-66

Newman, M.B.; Misiuta, I.; Willing, A.E.; Zigova, T.; Karl, R.C.; Borlongan, C.V.; Sanberg, P.R. 2005: Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells and Development 14(1): 29-43

Jordan, V.C. 1989: Tumoristatic action of tamoxifen: experimental evidence for clinical application in stage i and Ii breast cancer. Journal of ChemoTherapy 1(4 Suppl): 1144-1147

Stein, H. 1963: Tumorlike Bone Hyperplasia as a Consequence of Athletic Overstrain. Der Radiologe 3: 501-503

Tritsch, H.; Kiessling, W. 1956: Tumorlike diseases of the reticular connective tissue of the skin. Archiv für Klinische und Experimentelle Dermatologie 203(1): 83-100

New, W.N. 1954: Tumorlike keratoses. United States Armed Forces Medical Journal 5(12): 1749-1763

Plate, A.-M.; Lee, S.J.; Steiner, G.; Posner, M.A. 2003: Tumorlike lesions and benign tumors of the hand and wrist. Journal of the American Academy of Orthopaedic Surgeons 11(2): 129-141

Montagnac, R.; Schillinger, F.; Achab, A.; Ciupea, A. 2005: Tumorlike muscular sarcoidosis with hypercalcemia and acute renal failure. Nephrologie and Therapeutique 1(4): 241-246

Donkol, R.H.; Monib, S.; Eltounsi, I. 2006: Tumorlike, iron-sparing foci of splenic hemosiderosis in a child with sickle cell anemia. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 25(12): 1607-1609

Al-Abadi, A.Mohammed.; Al-Harbi, A.Swaid.; Al-Mohaya, S.Ali.; Kechrid, M.; Azhari, O.; Shetia, S. 2006: Tumorlysis by dialysis. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 17(4): 589-595

Svoboda, M.; Sochmann, J.; Urbanova, D. 1962: Tumoroid roentgen picture of the esophagus in moniliasis. Radiologia Diagnostica 3: 79-85

Shafar, J.; Behr, G. 1965: Tumorous Abnormalities of Adipose Tissue. Postgraduate Medical Journal 41: 15-17

Danilova, L.A.; Soboleva, S.S. 1965: Tumorous Reticulosis of the Heart during Chronic Myelocytic Leukemia. Problemy Gematologii i Perelivaniia Krovi 10: 48-52

Puente Duany, N. 1958: Tumorous adenofibrolipomatous hyperplasia of periglandular fibrolipomatosis of the breast. Archivos Cubanos de Cancerologia 17(10-12): 361-376

Lui, P.C.W.; Pang, L.-M.; Hlaing, T.-T.; Tse, G.M.K. 2004: Tumorous amyloidosis of the breast associated with disseminated malignant lymphoma. Journal of Clinical Pathology 57(3): 334-335

Hes, O.; Vanecek, T.; Síma, R.; Hora, M.; Velickinová, H.; Grossmann, P.; Kovár, J.; Michal, M. 2005: Tumorous diseases in patients with the testicular feminization syndrome ("androgen insensitivity" syndrome)--description of two cases. Ceska Gynekologie 70(2): 113-117

Dimitrov, S. 1953: Tumorous diseases of the breast. Khirurgiia 6(7): 385-387

Trebing, D.; Brunner, M.; Kröning, Y.; Seele, P. 2005: Tumorous extragenital manifestation of lymphogranuloma venereum. Journal der Deutschen Dermatologischen Gesellschaft 3(6): 445-447

Zberovskaia, N.V.; Iakovleva, I.I. 1958: Tumorous form of chronic lymphatic leukosis with affection of larynx, trachea and bronchi. Vestnik Otorinolaringologii 20(6): 118-119

Dustin, P. 1957: Tumorous hypertrophy of interstitial testicular gland in a pseudohermaphrodite with female morphology. Bruxelles Medical 37(23): 883-896

Matras, A. 1955: Tumorous lymphocytoma in atrophic skin. Archiv für Klinische und Experimentelle Dermatologie 200: 526-530

Chauvin, H.; Mirabel, J. 1950: Tumorous pericystitis developed around a urachal diverticulum containing a calculus. Marseille Chirurgical 2(1): 162-163

Dunner, L. 1957: Tumorous silicosis in polyarthritis; remarks on G. Sepke's paper. Der Tuberkulosearzt 11(7): 439-440